<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 11 MATERNAL AND CHILD HEALTH | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.11/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.11/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|11|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|11" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.11"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 11 MATERNAL AND CHILD HEALTH | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.11/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.11/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|11" data-search-heading="">
                  <span title="Subtitle 11 MATERNAL AND CHILD HEALTH">Subtitle 11 MATERNAL AND CHILD HEALTH</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|11">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.11">Subtitle 11 MATERNAL AND CHILD HEALTH</h1>
                <h2 id="/us/md/exec/comar/10.11.01" data-order="|10|11|01|" data-ref-path="10|11|01" class="h__chapter">Chapter 01 Identification of Infants</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Subtitle 11 Midwifery effective February 1, 1957; repealed effective July 12, 1987 (14:14 Md. R. 1572)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.01.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.01.03" title=".03 Identification of Newborn Infants — Mandatory Procedure.">.03</a> adopted effective December 25, 1989 (16:25 Md. R. 2710)</p>
                  <p>——————</p>
                  <p>Chapter revised effective April 6, 2009 (36:7 Md. R. 524)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b), 20-401, and 20-402, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.01.01" data-order="|10|11|01|.01|" data-ref-path="10|11|01|.01" class="h__section">.01 Scope.</h3>
                <p>These regulations affect all institutions or related facilities, as defined in <a class="internal-link " href="/us/md/exec/comar/10.11.01.02" title=".02 Definitions.">Regulation .02 of this chapter</a>, that deliver a newborn infant from its mother.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.01.02" data-order="|10|11|01|.02|" data-ref-path="10|11|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#A">A.</span> In these regulations, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(1)">(1)</span> "Born" means the complete expulsion or extraction of a product of human conception from its mother, regardless of the period of gestation, if, after the expulsion or extraction, it breathes or shows any other evidence of life, such as heartbeat, pulsation of the umbilical cord, or definite movement of voluntary muscle, whether or not the umbilical cord is cut or the placenta is attached.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(2)">(2)</span> "Cord blood sampling" means the taking of a sample of a newborn infant's blood from the infant's umbilical cord.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(3)">(3)</span> "Footprinting" means the taking of an ink or other type of impression of the skin patterns located on the sole of the newborn infant's foot.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(4)">(4)</span> "Institution" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(4)(a)">(a)</span> A hospital or related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(4)(b)">(b)</span> A freestanding birthing center as defined in Health-General Article, §19-1101, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(4)(c)">(c)</span> Any other facility that delivers an infant from its mother.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.02#B(5)">(5)</span> "Secretary" means the Secretary of Health or the Secretary's designee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.01.03" data-order="|10|11|01|.03|" data-ref-path="10|11|01|.03" class="h__section">.03 Identification of Newborn Infants — Mandatory Procedure.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#A">A.</span> An institution shall perform the infant identification procedures described in this regulation:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#A(1)">(1)</span> Immediately after the birth of the infant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#A(2)">(2)</span> Before the mother and infant are separated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#B">B.</span> An individual employed by the institution who attends the birth shall securely attach matching identification bands to the wrists of the mother and infant. An additional matching band may be attached the infant's father or another individual designated by the infant's mother.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C">C.</span> The matching identification bands shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(1)">(1)</span> The mother's name;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(2)">(2)</span> The same identification number for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(2)(a)">(a)</span> The infant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(2)(b)">(b)</span> The mother; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(2)(c)">(c)</span> If applicable, the father or any other designated person;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(3)">(3)</span> The infant's gender;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(4)">(4)</span> The date and time of birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#C(5)">(5)</span> Any other information specified by the institution's policy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#D">D.</span> In the case of multiple births:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#D(1)">(1)</span> The identification band for each infant shall also include the infant's birth order indicated either alphabetically such as by A, B, C or numerically such as by 1, 2, 3; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#D(2)">(2)</span> A band corresponding to each infant shall be attached to the mother.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#E">E.</span> Any unused band shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#E(1)">(1)</span> Attached to the mother;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#E(2)">(2)</span> Stapled to the mother's chart; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#E(3)">(3)</span> Disposed of in a secure disposal box.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#F">F.</span> An individual employed by the institution shall check the birth record and identification bands for accuracy before the mother or infant leaves the delivery room.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#G">G.</span> Each institution shall implement policies requiring personnel to check to ensure that the identification bands of a mother and her infant match:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#G(1)">(1)</span> Each time the infant is taken to the mother while at the institution; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.03#G(2)">(2)</span> At the time of the discharge of the mother and infant from the institution.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.01.04" data-order="|10|11|01|.04|" data-ref-path="10|11|01|.04" class="h__section">.04 Identification of Newborn Infants — Additional Procedures Permitted.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A">A.</span> An institution may perform additional identification procedures on an infant before the infant leaves the delivery room. These methods do not link mother and infant, but may be useful in establishing the identity of an infant, and include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A(1)">(1)</span> Cord blood sampling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A(2)">(2)</span> Footprinting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A(3)">(3)</span> Taking a color photograph of the infant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A(4)">(4)</span> Physically assessing the infant and documenting of any distinguishing features; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#A(5)">(5)</span> Another procedure proposed by the institution to the Secretary for approval that provides at least equivalent identification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B">B.</span> An institution proposing to the Secretary another procedure to identify newborn infants shall include in the proposal at least the following information:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(1)">(1)</span> Method of collection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(2)">(2)</span> Methods of storage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(3)">(3)</span> Specimen labeling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(4)">(4)</span> Specimen security and chain of custody;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(5)">(5)</span> Testing method, or methods to be used;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(6)">(6)</span> Circumstances for testing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(7)">(7)</span> Quality assurance of tests;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(8)">(8)</span> Confidentiality issues;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(9)">(9)</span> Protection against unauthorized access; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#B(10)">(10)</span> Record and documentation system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C">C.</span> Identification of Policies and Procedures. An institution shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)">(1)</span> Develop policies and methods for conducting each additional infant identification procedure under this regulation, and each procedure shall be documented with at least the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)(a)">(a)</span> Mother's name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)(b)">(b)</span> Mother's patient identification number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)(c)">(c)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)(d)">(d)</span> Gender of the newborn infant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(1)(e)">(e)</span> Birth order if a multiple birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#C(2)">(2)</span> Designate and train personnel responsible for performing newborn infant identification procedures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D">D.</span> Verification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D(1)">(1)</span> An institution shall verify that the identification procedure was performed by completing a form supplied by the institution or related facility. Information on the form shall include, but need not be limited to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D(1)(a)">(a)</span> Type of identification procedures performed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D(1)(b)">(b)</span> Date and time the identification procedure was performed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D(1)(c)">(c)</span> Name of personnel performing the identification procedure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#D(2)">(2)</span> An institution shall enter this form, which lists at least the information required in §D(1)(a), (b), and (c), of this regulation, into the infant's institutional medical record and maintain it as part of the infant's overall institutional record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.01.04#E">E.</span> Retention. An institution shall retain any identifying material (blood sample or footprint) for at least 10 days or until the newborn is discharged, whichever comes later.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.02" data-order="|10|11|02|" data-ref-path="10|11|02" class="h__chapter">Chapter 02 Early Hearing Detection and Intervention Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 20, 1992 (19:1 Md. R. 32)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.02.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.02.09" title=".09 Department Procedures.">.09</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.02.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.02.09" title=".09 Department Procedures.">.09</a> adopted effective June 22, 2015 (42:12 Md. R. 762)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§13-601—13-605, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.02.01" data-order="|10|11|02|.01|" data-ref-path="10|11|02|.01" class="h__section">.01 Purpose.</h3>
                <p>The Early Hearing Detection and Intervention Program shall provide for the universal hearing screening of newborns and early identification and follow-up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech-language skills. The Program shall identify newborns and infants who have a permanent hearing status that affects speech-language skills as early as possible.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.02" data-order="|10|11|02|.02|" data-ref-path="10|11|02|.02" class="h__section">.02 Scope.</h3>
                <p>This chapter requires the screening of all newborns and infants born in Maryland and follow-up for those who have, or are at risk for developing, a permanent hearing status that affects speech-language skills.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.03" data-order="|10|11|02|.03|" data-ref-path="10|11|02|.03" class="h__section">.03 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(1)">(1)</span> “Alternative birthing site” means any site of birth other than a hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(2)">(2)</span> “Appropriate services” mean any necessary audiological, medical, developmental, speech-language, sign language, psychosocial, educational, or intervention services required in the follow-up of newborns and infants who have or are at risk for developing a permanent hearing status that affects speech-language skills.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(3)">(3)</span> “At risk for developing a permanent hearing status that affects speech-language skills” means an infant identified as having any risk factor listed in <a class="internal-link " href="/us/md/exec/comar/10.11.02.04" title=".04 High Risk Factors.">Regulation .04 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(4)">(4)</span> “Audiological assessment” means testing to determine status of the auditory mechanism.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(5)">(5)</span> “Audiologist” means an individual licensed to practice audiology by the Maryland Board of Examiners for Audiologists, Hearing Aid Dispensers, and Speech-Language Pathologists.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(6)">(6)</span> “Birthing hospital” means a medical facility licensed by the Department which provides obstetrical services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(7)">(7)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(8)">(8)</span> “Department database” means the computer data management system used to gather and maintain program data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(9)">(9)</span> “Early Hearing Detection and Intervention Advisory Council (Advisory Council)” means the 12-member advisory council appointed by the Secretary to provide advice and consultation to the Department concerning the Early Hearing Detection and Intervention Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(10)">(10)</span> “Early intervention system” means the total effort in the State, for children from birth to 5 years of age, to meet the needs of eligible children and the children’s families, including the efforts of the Maryland Early Hearing Detection and Intervention Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(11)">(11)</span> “Hearing screening” means behavioral, electrophysiological, or other procedures used to identify newborns and infants in need of diagnostic audiological assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(12)">(12)</span> “Hearing status” means the state of an individual’s ability to perceive sound, based on audiological assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(13)">(13)</span> “Infant” means a Maryland resident who is younger than 1 year old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(14)">(14)</span> “Infant with a permanent change in hearing status that affects speech-language skills” means an infant who has a status that is an atypical function of the auditory system or any nontransient hearing status of any type or degree which is sufficient to interfere with the acquisition and development of speech-language skills with or without the use of sound amplification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(15)">(15)</span> “Local education agency” means a public board of education and public school system legally constituted to administer and direct education and programs of education in the public elementary or secondary schools, including early childhood from birth through the end of high school or their equivalent, in Baltimore City and the 23 counties in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(16)">(16)</span> “Local health department” means the official public health agency of the local political subdivision affiliated with the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(17)">(17)</span> “Maryland Infants and Toddlers Program” means the program within the Maryland State Department of Education’s Division of Special Education/Early Intervention Services that provides early intervention services for children under Part C of the Individuals with Disabilities Education Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(18)">(18)</span> “Newborn” means a child up to 29 days old who is born in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(19)">(19)</span> “Parent” means a biological or adoptive parent, a legal guardian, another individual responsible for a child’s welfare, or a person appointed as the surrogate parent as defined in COMAR 13A.05.01.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(20)">(20)</span> “Primary care provider” means a licensed practitioner who is the primary coordinator of care for the individual, whose responsibility it is to provide accessible, continuous, comprehensive, and coordinated health care services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(21)">(21)</span> “Program” means the Early Hearing Detection and Intervention Program established by the Secretary that provides for the universal screening of newborns and early identification and follow-up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech-language skills.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(22)">(22)</span> “Referral” means directing the newborn or infant at risk for developing a permanent hearing status that affects speech-language skills and the newborn or infant’s parent or guardian to a professional for diagnostic audiological assessment or other appropriate services, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(23)">(23)</span> “Risk factors” means indicators that are associated with permanent congenital, delayed-onset, or progression to a hearing status that affects speech-language skills in childhood.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(24)">(24)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.03#B(25)">(25)</span> “Telephone resource line” means toll-free telephone access to the Program inside Maryland through live voice or recorded message that is compatible with telecommunication relay services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.04" data-order="|10|11|02|.04|" data-ref-path="10|11|02|.04" class="h__section">.04 High Risk Factors.</h3>
                <p>Any of the following high risk factors are considered relevant in determining the possibility of a newborn or infant developing a permanent hearing status that affects speech-language skills under this chapter:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#A">A.</span> Caregiver concern regarding hearing, speech, language, or developmental delay;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#B">B.</span> Family history of a permanent hearing status that affects speech-language skills occurring during childhood;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C">C.</span> Medical risk factors:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(1)">(1)</span> Neonatal intensive care for more than 5 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(2)">(2)</span> Extracorporeal membrane oxygenation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(3)">(3)</span> Assisted ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(4)">(4)</span> Hyperbilirubinemia that requires exchange transfusion of the blood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(5)">(5)</span> Exposure to ototoxic medications, such as gentimycin and tobramycin; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#C(6)">(6)</span> Exposure to loop diuretic medications, such as furosemide and lasix;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#D">D.</span> In utero infections, such as cytomegalovirus, herpes, rubella, syphilis, and toxoplasmosis;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#E">E.</span> Craniofacial anomalies;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#F">F.</span> Physical findings associated with a permanent hearing status that affects speech-language skills;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#G">G.</span> Diagnosis of a syndrome associated with a congenital or progressive change in hearing status that affects speech-language skills;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#H">H.</span> Neurodegenerative disorders, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#H(1)">(1)</span> Hunter syndrome; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#H(2)">(2)</span> Sensory motor neuropathies, such as Friedrich’s Ataxia and Charcot-Marie-Tooth disease;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#I">I.</span> Culture-positive postnatal infections associated with a permanent change in hearing status that affects speech-language skills, including bacterial and viral meningitis;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#J">J.</span> Head trauma, including basal skull and temporal bone fracture, that require hospitalization; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.04#K">K.</span> Chemotherapy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.05" data-order="|10|11|02|.05|" data-ref-path="10|11|02|.05" class="h__section">.05 Model System.</h3>
                <p>The Department shall establish and maintain a model system to provide for the implementation of an early identification program and follow-up of newborns and infants who have or are at risk for developing a permanent hearing status that affects speech-language skills and includes the following components:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#A">A.</span> Educational materials;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#B">B.</span> Telephone resource line;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#C">C.</span> Department database to gather and maintain program data;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#D">D.</span> A service referral directory;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#E">E.</span> In-service training of hospitals, local health departments, and local education agencies;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#F">F.</span> Referral to appropriate agency or professional for services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#G">G.</span> Program monitoring and review;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#H">H.</span> Confidentiality of records and information in accordance with Health-General Article, §§4-101 and 4-301 — 4-309, Annotated Code of Maryland; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#I">I.</span> Continuum of follow-up which includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#I(1)">(1)</span> Contacting the primary care provider in writing or by telephone to verify the status of the infant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#I(2)">(2)</span> Contacting parents or guardians in writing or by telephone to facilitate referral for diagnostic audiological assessment and referral for appropriate services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.05#I(3)">(3)</span> Interfacing with the single point of entry for the early intervention system.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.06" data-order="|10|11|02|.06|" data-ref-path="10|11|02|.06" class="h__section">.06 Early Hearing Detection and Intervention Advisory Council.</h3>
                <p>The Advisory Council shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#A">A.</span> Advise the Department on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#A(1)">(1)</span> The implementation of an early identification program and follow-up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech-language skills;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#A(2)">(2)</span> Setting of standards for the Program including procedures for hearing screening;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#A(3)">(3)</span> Monitoring and reviewing of the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#A(4)">(4)</span> Provision of quality assurance for the Program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#B">B.</span> Provide consultation to the Department in the development of the Program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#C">C.</span> Make recommendations for operation of the Program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#D">D.</span> Provide consultation to the Department in the maintenance of an educational program for families, professionals, and the public integrated with the Maryland Infants and Toddlers Program and local early intervention systems, including existing State and local education agency programs;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#E">E.</span> Review any materials the Department may distribute to the public concerning newborns and infants who have a permanent hearing status that affects speech-language skills;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#F">F.</span> Meet annually with the Secretary or the Secretary’s designee; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.06#G">G.</span> Provide consultation to the Department in the adoption of rules and regulations necessary to implement the Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.07" data-order="|10|11|02|.07|" data-ref-path="10|11|02|.07" class="h__section">.07 Procedures for Birthing Hospitals and Alternative Birthing Sites.</h3>
                <p>For each infant delivered at the facility or site, birthing hospital staff and, in the cases of alternative birthing sites, the licensed professional attending the birth shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#A">A.</span> Within 48 hours of delivery, enter demographic and birth event data into the Department database;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B">B.</span> Within 48 hours of discharge from care in the Department database:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(1)">(1)</span> Document:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(1)(a)">(a)</span> The hearing screening test results; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(1)(b)">(b)</span> Any known risk factors; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(2)">(2)</span> Identify and document:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(2)(a)">(a)</span> The infant’s primary care provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#B(2)(b)">(b)</span> Any referrals made; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#C">C.</span> Provide to the family:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#C(1)">(1)</span> Written documentation of the birth hearing screening results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#C(2)">(2)</span> Any identified risk factors; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.07#C(3)">(3)</span> Instructions for any recommended follow-up.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.08" data-order="|10|11|02|.08|" data-ref-path="10|11|02|.08" class="h__section">.08 Procedures for Audiologists and Licensed Professionals Conducting Audiological Screening or Evaluations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A">A.</span> An audiologist or a licensed professional who performs a hearing screening or audiological diagnostic evaluation on a child younger than 5 years old due to the presence of a risk factor as listed in <a class="internal-link " href="/us/md/exec/comar/10.11.02.04" title=".04 High Risk Factors.">Regulation .04 of this chapter</a> or in follow-up to the birth hearing screening of a newborn or infant who did not receive or did not pass the birth hearing screening shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A(1)">(1)</span> Within 2 business days:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A(1)(a)">(a)</span> Report the results of the screening or audiological diagnostic evaluation to the Program in the Department database;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A(1)(b)">(b)</span> Document recommendations and referrals provided in the Department database; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A(1)(c)">(c)</span> Confirm or update the demographic information of the child or infant in the Department database; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#A(2)">(2)</span> Within 7 business days, notify the appropriate early intervention program at the Maryland State Department of Education of any child younger than 5 years old confirmed to have or strongly suspected of having a permanent hearing status of any type or degree as described in <a class="internal-link " href="/us/md/exec/comar/10.11.02.08#B" title="">§B of this regulation</a> which is sufficient to interfere with the acquisition and development of speech-language skills with or without the use of sound amplification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.08#B">B.</span> A child younger than 5 years old is strongly suspected of having a permanent hearing status if evidence or clinical judgment exists which indicates that there is a high probability of a permanent hearing status of any type or degree which is sufficient to interfere with the acquisition and development of speech-language skills.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.02.09" data-order="|10|11|02|.09|" data-ref-path="10|11|02|.09" class="h__section">.09 Department Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A">A.</span> The Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(1)">(1)</span> Implement the model system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(2)">(2)</span> Perform duties and responsibilities in accordance with the advice and consultation of the Advisory Council;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(3)">(3)</span> Exercise independent judgment in the day-to-day operations of the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(4)">(4)</span> Develop Program processes in consultation with the Advisory Council;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(5)">(5)</span> Conduct in-service training on Program procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(6)">(6)</span> Maintain a Department database to monitor infants at risk for developing a hearing status that affects speech-language skills;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(7)">(7)</span> Track infants identified as at risk for developing a permanent hearing status that affects speech-language skills for a period of 5 years;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(8)">(8)</span> Maintain a service directory within the Department database;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(9)">(9)</span> Assure operation of the telephone resource line;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(10)">(10)</span> Facilitate referral for diagnostic audiological assessment and early intervention for infants who are at risk for developing a permanent hearing status that affects speech-language skills;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(11)">(11)</span> Maintain records of the audiological assessment reports for infants at risk for developing a permanent hearing status that affects speech-language skills; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#A(12)">(12)</span> Interface with the single point of entry of the early intervention system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.02.09#B">B.</span> The Secretary shall establish guidelines for the operation of the Advisory Council.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.03" data-order="|10|11|03|" data-ref-path="10|11|03" class="h__chapter">Chapter 03 Children's Medical Services Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 21, 1986 (13:19 Md. R. 2121)</p>
                  <p>Regulations .03, .05, and .12 amended as an emergency provision effective January 1, 1987 (14:2 Md. R. 125); adopted permanently effective March 31, 1987 (14:6 Md. R. 715)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.12" title=".12 Conditions of Hospital Participation.">Regulation .12</a> amended effective August 24, 1987 (14:17 Md. R. 1871)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.01" title=".01 Incorporation by Reference.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.12" title=".12 Conditions of Hospital Participation.">.12</a> repealed effective November 28, 1988 (15:24 Md. R. 2769)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.01" title=".01 Incorporation by Reference.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.18" title=".18 Billing Procedures for Pharmacy Services.">.18</a> adopted effective November 28, 1988 (15:24 Md. R. 2769)</p>
                  <p>——————</p>
                  <p>Chapter revised and recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.22.08" title="Chapter 08 Community Residential Services Program Service Plan">COMAR 10.22.08</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03" title="Chapter 03 Children's Medical Services Program">COMAR 10.11.03</a> effective March 1, 1993 (20:4 Md. R. 371)</p>
                  <p>Regulation .01-1 adopted as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); adopted permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.02#A" title="">Regulation .02A</a>, B amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p>Regulations .03 and .08 amended as an emergency provision effective January 27, 1999 (26:4 Md. R. 269); amended permanently effective May 31, 1999 (26:11 Md. R. 855)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.03#B" title="">Regulation .03B</a> amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.03#B" title="">Regulation .03B</a> amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p>Regulation .08C amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .08E amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.10" title=".10 Record Retention and Confidentiality.">Regulation .10</a> amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p>Regulation .10D-1 adopted effective March 28, 1994 (21:6 Md. R. 467)</p>
                  <p>Regulation .10E—I repealed as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .20C amended effective April 24, 1995 (22:8 Md. R. 596)</p>
                  <p>Regulation .20F repealed as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .21C amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .23 amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .25D amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .26 amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .27 amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .28A amended effective March 28, 1994 (21:6 Md. R. 467)</p>
                  <p>Regulation .30 repealed, new Regulations .30 and .31 adopted, and Regulation .31 recodified to Regulation .32 as an emergency provision effective January 27, 1999 (26:4 Md. R. 269); amended permanently effective May 31, 1999 (26:11 Md. R. 855)</p>
                  <p>Regulation .30 amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .30 repealed and new Regulation .30 adopted as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); adopted permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p>Regulation .30A amended effective March 28, 1994 (21:6 Md. R. 467); April 24, 1995 (22:8 Md. R. 596)</p>
                  <p>Regulation .31 adopted effective March 28, 1994 (21:6 Md. R. 467)</p>
                  <p>Regulation .31 amended as an emergency provision effective January 19, 2007 (34:4 Md. R. 396); amended permanently effective May 7, 2007 (34:9 Md. R. 825)</p>
                  <p>Regulation .31 repealed and new Regulation .31 adopted as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); adopted permanently effective January 14, 2008 (35:1 Md. R. 19)</p>
                  <p>——————</p>
                  <p>Chapter revised effective April 13, 2015 (42:7 Md. R. 568)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.03.14#B" title="">Regulation .14B</a> amended effective February 27, 2017 (44:4 Md. R. 252)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §15-125, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.03.01" data-order="|10|11|03|.01|" data-ref-path="10|11|03|.01" class="h__section">.01 Incorporation by Reference.</h3>
                <p>In this chapter, the federal poverty guidelines, as amended, which are updated periodically in the Federal Register by the U.S. Department of Health and Human Services, are incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.02" data-order="|10|11|03|.02|" data-ref-path="10|11|03|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(1)">(1)</span> "Agency" means a legally incorporated body or governmental unit which provides services to disabled children or their families, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(2)">(2)</span> "Allowable cost" means the maximum amount which the Program will reimburse for the drug or product portion of the prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(3)">(3)</span> “Appeal” means the process by which a child with special health care needs, as defined in <a class="internal-link " href="/us/md/exec/comar/10.11.03.02#B(9)" title="">§B(9) of this regulation</a>, or the family on the child’s behalf, obtains a review of a decision, action, or lack of action on the part of the CMS Program or one of its designees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(4)">(4)</span> “Applicant” means a child with special health care needs, as defined in <a class="internal-link " href="/us/md/exec/comar/10.11.03.02#B(9)" title="">§B(9) of this regulation</a>, or the parent or guardian of a child, for whom a written application has been submitted to the CMS Program for services, but for whom eligibility has not yet been determined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(5)">(5)</span> “Authorized services” means that care which is approved by the CMS Program for an eligible child.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(6)">(6)</span> “Care coordination services” means services to promote the effective and efficient utilization of resources to assure access to necessary comprehensive services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(7)">(7)</span> “Care management plan (CMP)” means a written document that lists recommendations for care as specified by a licensed and boarded provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)">(8)</span> “Children’s Medical Services Program (CMS Program)” means that program which is administered by the Department pursuant to Health-General Article, §15-125, Annotated Code of Maryland, to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)(a)">(a)</span> Provide for specialized medical, surgical, pharmacologic, and related rehabilitative evaluation and treatment services for children with special health care needs younger than 22 years old who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)(a)(i)">(i)</span> Meet the residential, identification, financial, and medical eligibility requirements; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)(a)(ii)">(ii)</span> Are uninsured or do not have coverage in their existing health insurance plans that cover certain types of medical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)(b)">(b)</span> Provide and promote family-centered, community-based, coordinated care for children with special health care needs, and promote development of community-based, culturally competent systems of services for those children and their families throughout the State; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(8)(c)">(c)</span> Distribute funds to cover specialty diagnostic and treatment services for eligible children with special health care needs in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(9)">(9)</span> “Children with special health care needs” means individuals, birth to 22 years old, who have or who are at increased risk for a chronic physical, development, behavioral, or emotional condition and who also require health and related services of a type or amount beyond that required by children generally.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(10)">(10)</span> “Department” means the Maryland Department of Health, the single State agency designated to administer the CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(11)">(11)</span> "Disabling condition" means a health-related condition or impairment that may hinder achievement of normal growth and development.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(12)">(12)</span> "Disposable medical supplies" means consumable or disposable items with minimal or no potential for reuse which are used to serve a medical purpose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(13)">(13)</span> "Durable medical equipment" means equipment which satisfies all of the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(13)(a)">(a)</span> It can withstand repeated use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(13)(b)">(b)</span> It is used to serve a medical purpose; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(13)(c)">(c)</span> It is appropriate for use in the home.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(14)">(14)</span> “Federal poverty level” means the poverty guidelines, as amended, which are updated periodically in the Federal Register by the U.S. Department of Health and Human Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(15)">(15)</span> “Financial eligibility guidelines” means the schedule based upon the federal poverty level which is used to determine financial eligibility for the CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(16)">(16)</span> "General hospital" means an institution which falls within the jurisdiction of Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland, and is licensed as a general hospital by the Maryland Department of Health, Division of Licensing and Certification, in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(17)">(17)</span> "Health Services Cost Review Commission (HSCRC)" means the independent organization within the Maryland Department of Health which is responsible for reviewing and approving rates for hospitals pursuant to Health-General Article, Title 19, Subtitle 2, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(18)">(18)</span> "Hospital" means an institution which falls within the jurisdiction of Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland, and is licensed pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a>, or other applicable standards established by the state in which the services are provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(19)">(19)</span> "Income" means any property or service received by a person in cash or in kind which can be applied directly to meet basic needs for food, shelter, and medical expenses.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(20)">(20)</span> "Long-term hospitalization" means an inpatient stay of more than 2 weeks.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(21)">(21)</span> “Medical assistance” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(22)">(22)</span> ”Medical care” means medical services and specialized care provided by physicians and allied health professionals in hospitals, convalescent facilities, clinics, private physicians’ offices, in home and other community-based settings. Medical care may include the services rendered by dentists, nurses, medical social workers, childlife specialists, nutritionists, dietitians, psychologists, physical therapists, occupational therapists, speech-language pathologists, audiologists, optometrists, ophthalmologists, technicians, and other pertinent personnel whose services may be needed by those children who are served by the CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(23)">(23)</span> "Medically necessary dental care" means reasonable and appropriate diagnosis, treatment, and follow-up care as determined and prescribed by qualified, appropriate health care providers in treating a condition, disease, injury, birth defect, or development malformation to restore facial configuration or function necessary for speech, swallowing, or chewing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(24)">(24)</span> "Physician specialist" means a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(24)(a)">(a)</span> Licensed medical doctor who is qualified to practice medicine in a specialty area and who is either board certified or board eligible and who has experience in the care of children; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(24)(b)">(b)</span> Resident physician under the supervision of a licensed board-certified physician.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(25)">(25)</span> "Preauthorization" means an approval required from the Department or its designee before the provision of services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(26)">(26)</span> “Provider” means an individual or entity duly licensed or certified to render a health care service or product pursuant to these regulations through an appropriate agreement with the Department, and identified as a CMS Program provider by the issuance of an individual vendor number.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.02#B(27)">(27)</span> ”Residency” means living in the State voluntarily with the intention of making the State the individual’s permanent home for an indefinite period and not for a temporary purpose.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.03" data-order="|10|11|03|.03|" data-ref-path="10|11|03|.03" class="h__section">.03 Covered Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#A">A.</span> The CMS Program shall authorize covered services when a CMP has been approved.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B">B.</span> The CMP shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)">(1)</span> Include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(a)">(a)</span> All diagnoses or suspected diagnoses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(b)">(b)</span> Service requested or provided;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(c)">(c)</span> Specific reason for the service request;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(d)">(d)</span> Evaluation or treatment findings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(e)">(e)</span> Follow-up plans related to the service provided by the CMS Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(1)(f)">(f)</span> Source of primary health care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#B(2)">(2)</span> Be reviewed and approved by the CMS Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#C">C.</span> The CMS Program may request further information from the provider in order to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#C(1)">(1)</span> Support the information required in <a class="internal-link " href="/us/md/exec/comar/10.11.03.03#B(1)" title="">§B(1) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#C(2)">(2)</span> Assure that all services are coordinated with other services the child is receiving through the CMS Program or other programs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#C(3)">(3)</span> Assure that the needs of the family are addressed in relation to meeting the medical and developmental needs of the child.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D">D.</span> CMS Program eligible services shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(1)">(1)</span> Specialty clinics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)">(2)</span> Private office care including, but not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(a)">(a)</span> Allergy/Immunology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(b)">(b)</span> Audiology and hearing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(c)">(c)</span> Cardiology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(d)">(d)</span> Craniofacial;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(e)">(e)</span> Cystic fibrosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(f)">(f)</span> Developmental pediatrics;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(g)">(g)</span> Endocrine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(h)">(h)</span> Gastroenterology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(i)">(i)</span> Genetics;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(j)">(j)</span> Hematology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(k)">(k)</span> Infectious disease;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(l)">(l)</span> Nephrology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(m)">(m)</span> Neurology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(n)">(n)</span> Neurosurgery;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(o)">(o)</span> Oncology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(p)">(p)</span> Ophthalmology, optometry, and vision;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(q)">(q)</span> Orthopedics;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(r)">(r)</span> Otolaryngology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(s)">(s)</span> Physical medicine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(t)">(t)</span> Plastic surgery;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(u)">(u)</span> Pulmonology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(v)">(v)</span> Rheumatology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(w)">(w)</span> Speech-language pathology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(x)">(x)</span> Surgery; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(2)(y)">(y)</span> Urology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(3)">(3)</span> Primary physician care arranged at the discretion of the CMS Program to assure access for needed specialty diagnostic evaluation, treatment, and care coordination services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(4)">(4)</span> Inpatient hospital care services, which are provided by Medical Assistance affiliated hospitals; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)">(5)</span> Professional evaluation and treatment services, which may include, but are not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(a)">(a)</span> Audiology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(b)">(b)</span> Family training and counseling regarding medical and rehabilitation needs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(c)">(c)</span> Genetic counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(d)">(d)</span> Nursing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(e)">(e)</span> Nutrition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(f)">(f)</span> Occupational therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(g)">(g)</span> Physical therapy; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#D(5)(h)">(h)</span> Speech-language pathology.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E">E.</span> Specialized activities to facilitate a special treatment program may include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(1)">(1)</span> Equipment to provide:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(1)(a)">(a)</span> Life support;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(1)(b)">(b)</span> Mobility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(1)(c)">(c)</span> Stimulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(1)(d)">(d)</span> Aid in activities of daily living;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(2)">(2)</span> Orthoses to correct or prevent orthopedic disabilities, including prescription shoes and their modifications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(3)">(3)</span> Prostheses to replace a missing part or to enhance the applicant's functional performance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(4)">(4)</span> Formula and medication to correct metabolic and physiologic errors;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(5)">(5)</span> Supplies of durable and disposable items to facilitate management of specific disorders;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(6)">(6)</span> Approved therapies involving specific treatment as authorized by appropriate CMS Program professional staff to cure functional deficiencies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(7)">(7)</span> Life sustaining medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(8)">(8)</span> Dental services provided for children with disabling conditions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.03#E(9)">(9)</span> Hearing aids and augmentative devices to improve communication.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.04" data-order="|10|11|03|.04|" data-ref-path="10|11|03|.04" class="h__section">.04 Rights and Responsibilities.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#A">A.</span> Applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#A(1)">(1)</span> The applicant shall furnish factual information regarding the applicant’s eligibility, and shall keep the CMS Program informed of any change in demographic, financial, medical, or insurance coverage status.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#A(2)">(2)</span> An eligible applicant shall use only Medical Assistance approved providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#A(3)">(3)</span> An applicant shall complete a Medical Assistance application when the applicant is considered potentially eligible.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B">B.</span> CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(1)">(1)</span> An applicant who meets eligibility criteria as set forth in this chapter shall have access to approved services within the budgetary limitations of the CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)">(2)</span> The CMS Program may purchase health insurance benefits for an eligible child when all of the following conditions are met:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(a)">(a)</span> The cost of this expense is less than the cost of directly purchasing the child’s medical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)">(b)</span> The policyholder is unable to pay for the health insurance policy due to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)(i)">(i)</span> An increase in insurance cost;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)(ii)">(ii)</span> A change in employment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)(iii)">(iii)</span> Loss of income;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)(iv)">(iv)</span> An increase in health-related expenses; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(b)(v)">(v)</span> The policyholder’s eligibility to purchase health insurance benefits in accordance with the Consolidated Omnibus Budget Reconciliations Act of 1985, P.L. 99-272;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)">(c)</span> The health insurance policy is issued directly from:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)(i)">(i)</span> An authorized insurer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)(ii)">(ii)</span> A nonprofit health services plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)(iii)">(iii)</span> A health maintenance organization;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)(iv)">(iv)</span> A self-insured health benefit plan; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(c)(v)">(v)</span> The employer of the family member whose health insurance provides coverage for the eligible child; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(2)(d)">(d)</span> Payment is for premiums that can be costed out as related to the applicant only.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(3)">(3)</span> The CMS Program may pay copays, deductibles, and coinsurance costs when the CMS Program is purchasing the health insurance benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(4)">(4)</span> The CMS Program shall comply with the requirements of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(4)(a)">(a)</span> Title VI of the Civil Rights Act of 1964 as amended;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(4)(b)">(b)</span> The Age Discrimination Act of 1975 as amended;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(4)(c)">(c)</span> Section 504 of the Rehabilitation Act of 1973 as amended; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(4)(d)">(d)</span> The Americans with Disabilities Act of 1989.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(5)">(5)</span> The CMS Program shall determine financial assistance based on the income and allowable deductions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(6)">(6)</span> The CMS Program shall provide full financial assistance for authorized services when the income is equal to or less than that which is allowable in accordance with the financial eligibility levels described in <a class="internal-link " href="/us/md/exec/comar/10.11.03.05#A(4)" title="">Regulation .05A(4) of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.04#B(7)">(7)</span> The CMS Program shall provide full CMS Program eligible service to the extent that medical assistance for this service is not covered under Title XIX.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.05" data-order="|10|11|03|.05|" data-ref-path="10|11|03|.05" class="h__section">.05 General Eligibility Criteria.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A">A.</span> To be eligible for the CMS Program’s services, an applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(1)">(1)</span> Submit a completed, signed, and dated CMS Program application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(2)">(2)</span> Provide documentation of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(2)(a)">(a)</span> State residency, as this program is not meant to cover those whose sole purpose in coming to Maryland is to obtain medical care or coverage; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(2)(b)">(b)</span> Being younger than 22 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(3)">(3)</span> Provide a form of identification for the applicant and the applicant’s parents or guardians if the applicant is less than 18 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(4)">(4)</span> Have income that does not exceed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(4)(a)">(a)</span> 200 percent of the federal poverty level; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(4)(b)">(b)</span> 250 percent of the federal poverty level, if the applicant is eligible for a medical deduction under <a class="internal-link " href="/us/md/exec/comar/10.11.03.07#D" title="">Regulation .07D of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#A(5)">(5)</span> Have an eligible medical condition as set forth in <a class="internal-link " href="/us/md/exec/comar/10.11.03.06" title=".06 Medical Eligibility.">Regulation .06 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#B">B.</span> The age eligibility referred to in <a class="internal-link " href="/us/md/exec/comar/10.11.03.05#A(2)(b)" title="">§A(2)(b) of this regulation</a> may be extended 3 years beyond the 22nd birthday if the CMP:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#B(1)">(1)</span> Confirms that current treatment of the condition should be continued in order to prevent a significant disruption in the provision of necessary services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.05#B(2)">(2)</span> Documents that the applicant is without third-party insurance or entitlement coverage.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.06" data-order="|10|11|03|.06|" data-ref-path="10|11|03|.06" class="h__section">.06 Medical Eligibility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#A">A.</span> Children with special health care needs may be eligible for services covered by the CMS Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B">B.</span> Chronic medical conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(1)">(1)</span> Chronic asthma;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(2)">(2)</span> Chronic renal disease;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(3)">(3)</span> Cystic fibrosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(4)">(4)</span> Diabetes and other endocrine disorders;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(5)">(5)</span> Hemophilia;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(6)">(6)</span> Immune deficiencies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(7)">(7)</span> Juvenile rheumatoid arthritis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(8)">(8)</span> Leukemia and other childhood cancers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(9)">(9)</span> Phenylketonuria and other inborn errors of metabolism; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#B(10)">(10)</span> Sickle cell anemia and other chronic anemia.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#C">C.</span> Other medical and surgical conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#C(1)">(1)</span> Biliary atresia;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#C(2)">(2)</span> Bronchopulmonary dysplasia;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#C(3)">(3)</span> Tracheal esophogeal fistula; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#C(4)">(4)</span> Ulcerative colitis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D">D.</span> Neurodevelopmental conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(1)">(1)</span> Brain tumors;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(2)">(2)</span> Cerebral palsy and other central nervous system disorders;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(3)">(3)</span> Certain high risk neonates;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(4)">(4)</span> Closed head injury with residual defects;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(5)">(5)</span> Down's syndrome and other genetic and chromosomal anomalies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(6)">(6)</span> Hydrocephalus;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(7)">(7)</span> Medical aspects of learning disabilities and attention deficit disorders;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(8)">(8)</span> Medical aspects of intellectual disability and developmental delay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(9)">(9)</span> Muscular atrophies and dystrophies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(10)">(10)</span> Spina bifida, myelomeningocele, and the spinal cord dysfunctions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(11)">(11)</span> Other neurologic damage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(12)">(12)</span> Peripheral neuromuscular disease; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#D(13)">(13)</span> Seizure disorder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E">E.</span> Orthopedic conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(1)">(1)</span> Chronic conditions resulting from trauma;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(2)">(2)</span> Chronic infections of bones and joints;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(3)">(3)</span> Club foot and other foot deformities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(4)">(4)</span> Congenital developmental hip conditions such as congenital hip dislocation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(5)">(5)</span> Limb deficiencies and length discrepancies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(6)">(6)</span> Skeletal dysplasias and other forms of dwarfism; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#E(7)">(7)</span> Spinal column defects and deformities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#F">F.</span> Cardiac conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#F(1)">(1)</span> Arrhythmias;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#F(2)">(2)</span> Congenital heart defects;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#F(3)">(3)</span> Hypertension; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#F(4)">(4)</span> Rheumatic heart disease.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#G">G.</span> Craniofacial and dental conditions which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#G(1)">(1)</span> Cleft lip and palate, orofacial defects;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#G(2)">(2)</span> Handicapping malocclusions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#G(3)">(3)</span> Medically necessary dental care related to eligible medical conditions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H">H.</span> Vision, hearing and speech-language conditions, which may render an applicant medically eligible include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(1)">(1)</span> Amblyopia;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(2)">(2)</span> Cataract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(3)">(3)</span> Cholesteatoma;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(4)">(4)</span> Chronic otitis media;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(5)">(5)</span> Conductive and sensory-neural hearing loss;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(6)">(6)</span> Otosclerosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(7)">(7)</span> Speech-language disorders;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(8)">(8)</span> Strabismus; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#H(9)">(9)</span> Velopharyngeal incompetence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#I">I.</span> The following are excluded from CMS Program medically eligible services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#I(1)">(1)</span> Well child care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#I(2)">(2)</span> Mental health;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#I(3)">(3)</span> Emergency care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#I(4)">(4)</span> Urgent care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#J">J.</span> Care excluded from CMS Program medically eligible conditions unless the services are medically necessary due to the underlying chronic condition includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#J(1)">(1)</span> Dermatology;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#J(2)">(2)</span> Gynecology; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.06#J(3)">(3)</span> Dental services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.07" data-order="|10|11|03|.07|" data-ref-path="10|11|03|.07" class="h__section">.07 Financial Eligibility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#A">A.</span> An applicant's financial eligibility is based upon the composition and income of the family unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B">B.</span> Family Unit. A family unit consists of one or more of the following members residing in the same household:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B(1)">(1)</span> The applicant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B(2)">(2)</span> The natural or adoptive parents, stepparents, or legal guardian if the applicant is unmarried;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B(3)">(3)</span> The unmarried natural or adoptive siblings of the applicant who are younger than 22 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B(4)">(4)</span> The lawful spouse of the applicant; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#B(5)">(5)</span> Other individuals who are not included in this regulation and who are dependents for federal income tax purposes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C">C.</span> Income.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(1)">(1)</span> For the purpose of determining financial eligibility, the CMS Program shall treat the income of members of the family unit listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.07#B" title="">§B of this regulation</a> as the sole source for determining an applicant’s eligibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)">(2)</span> The CMS Program shall determine the family’s income from the following sources:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(a)">(a)</span> Wages, including sick or severance pay;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(b)">(b)</span> Commissions and fees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(c)">(c)</span> Salaries and tips;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(d)">(d)</span> Profit from self-employment, including income from the operation of a farm;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(e)">(e)</span> The earned income tax credit (EITC);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(f)">(f)</span> Social Security benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(g)">(g)</span> Veterans' Administration benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(h)">(h)</span> Workers' Compensation benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(i)">(i)</span> Black Lung or Agent Orange benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(j)">(j)</span> Railroad Retirement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(k)">(k)</span> Government, private, or company pensions and annuities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(l)">(l)</span> Unemployment insurance benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(m)">(m)</span> Payments from oil or mineral rights (leases);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(n)">(n)</span> Government payments on land;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(o)">(o)</span> Insurance benefits paid directly to an applicant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(p)">(p)</span> Trust funds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(q)">(q)</span> Individual retirement accounts (IRAs);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(r)">(r)</span> Keough plans;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(s)">(s)</span> Military allotments;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(t)">(t)</span> Alimony or court-ordered and voluntary child support payments received from an absent spouse, or an absent natural or adoptive parent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(u)">(u)</span> Loan repayments made to the applicant or family member including, but not limited to, mortgage payments;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(v)">(v)</span> Lump-sum benefits or other amounts of income received on a one-time-only basis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(w)">(w)</span> Profit from rental income;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(x)">(x)</span> Cash assistance received from non-governmental social service agencies greater than the amount allowed by Medical Assistance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(y)">(y)</span> Sick pay which does not count as earnings for deduction purposes under Title II of the Social Security Act; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(2)(z)">(z)</span> Any subsidy covering basic needs for food or shelter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(3)">(3)</span> If an individual in the family unit has recently resumed employment, the Program shall determine income for a 12-month period by averaging actual income for 6 months preceding resumption of employment and projected income for 6 months following resumption of employment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#C(4)">(4)</span> If additional CMS Program services are requested 6 months after resuming employment, the CMS Program may re-determine financial eligibility based on current income.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#D">D.</span> Medical Deductions. The applicant may deduct the following from the applicant’s income:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#D(1)">(1)</span> Loan payments related to medical or medically related emergency debt;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#D(2)">(2)</span> Payment to a hospital or other health care provider for a member of the family unit not covered by other third-party insurance entitlements, or the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#D(3)">(3)</span> Payments for health insurance for a member of the family unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E">E.</span> Effective Dates for Financial Eligibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E(1)">(1)</span> The CMS Program shall establish financial eligibility for a 12-month period from the date a completed application is received by the CMS Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E(2)">(2)</span> Exceptions to the 12-month financial eligibility period are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E(2)(a)">(a)</span> If financial eligibility was determined by averaging the previous 6 months, financial eligibility shall be reconsidered after 6 months;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E(2)(b)">(b)</span> When an eligible applicant enrolled in the CMS Program informs the CMS Program of changes in family size, income, or expense, the CMS Program may reconsider eligibility as soon as possible if financial assistance is being given, or when the next request for services is made.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.07#E(3)">(3)</span> Those receiving CMS Program financial assistance shall notify the CMS Program within 10 business days of any changes in circumstance which could affect continuing financial eligibility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.08" data-order="|10|11|03|.08|" data-ref-path="10|11|03|.08" class="h__section">.08 Application Process.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#A">A.</span> The CMS Program shall make applications available to, but which are not limited to, the following agencies:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#A(1)">(1)</span> Local health department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#A(2)">(2)</span> Admitting, social services, or business office of a participating hospital;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#A(3)">(3)</span> Cooperating agencies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#A(4)">(4)</span> An applicant, upon request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B">B.</span> Completion of Application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(1)">(1)</span> An applicant, the applicant's parent, guardian, or representative shall submit a complete, signed application approved by the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(2)">(2)</span> A parent of any age, or an authorized representative of the applicant who is 18 years old or older, shall complete and sign the application for an unmarried applicant younger than 18 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(3)">(3)</span> A representative of a public or private agency, which may include a foster parent, shall complete and sign the application for a child in custody of the agency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(4)">(4)</span> An applicant shall provide financial information for each employed member of the family unit as specified in <a class="internal-link " href="/us/md/exec/comar/10.11.03.07#A" title="">Regulation .07A of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(5)">(5)</span> An applicant shall provide documents verifying residency, identification, income, and medical conditions or suspected medical conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.08#B(6)">(6)</span> The CMS Program shall make reasonable accommodations to assure that appropriate assistance is provided to those who are disabled or who are unable to speak or write English.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.09" data-order="|10|11|03|.09|" data-ref-path="10|11|03|.09" class="h__section">.09 Disposition of Application.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A">A.</span> General.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)">(1)</span> The CMS Program professional staff shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)(a)">(a)</span> Review individual applications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)(b)">(b)</span> Determine CMS Program eligibility and services to be approved for payment by the CMS Program within 30 calendar days of receipt of the complete application;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)(c)">(c)</span> Verify the information provided by an applicant which may include an interview:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)(c)(i)">(i)</span> With the applicant if the applicant is 18 years old or older, or with the applicant’s parent or guardian; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(1)(c)(ii)">(ii)</span> Which is held at a mutually convenient place and time for all parties.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(2)">(2)</span> If additional information is needed to determine eligibility or service needed, the Program shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(2)(a)">(a)</span> Return the application within 15 business days of receipt; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(2)(b)">(b)</span> Advise an applicant in writing of needed documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(3)">(3)</span> Within 30 calendar days of receipt of the completed application by the CMS Program the CMS Program shall send a written decision regarding Program eligibility to the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#A(4)">(4)</span> For renewal applications, the CMS Program shall notify an applicant in writing at least 30 calendar days before the date on which the applicant shall reapply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#B">B.</span> Eligible Applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#B(1)">(1)</span> An eligible applicant shall receive a letter from the CMS Program which includes, at a minimum, the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#B(1)(a)">(a)</span> The effective dates of CMS Program eligibility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#B(1)(b)">(b)</span> The name of the provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#B(1)(c)">(c)</span> The service to be covered by the CMS Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C">C.</span> Ineligible Applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(1)">(1)</span> An applicant is ineligible when the applicant does not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(1)(a)">(a)</span> Provide requested information sufficient to determine eligibility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(1)(b)">(b)</span> Complete, sign, and date the application; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(1)(c)">(c)</span> Complete an application for Medical Assistance when the applicant is potentially eligible for services covered by Medical Assistance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(2)">(2)</span> An applicant determined ineligible shall receive a letter from the CMS Program informing the applicant of the reasons for the determination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#C(3)">(3)</span> An applicant determined to be ineligible shall be advised of the right to appeal the determination in accordance with the procedures set forth in <a class="internal-link " href="/us/md/exec/comar/10.11.03.09#D" title="">§D of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#D">D.</span> Appeal Rights.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#D(1)">(1)</span> Providers filing appeals of administrative decisions made in connection with these regulations shall do so in accordance with Health-General Article, §2-207, and <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.09#D(2)">(2)</span> An applicant or eligible individual, or other authorized representative has a right to a meeting or informal conference with CMS staff responsible for a decision reflected in any notice of determination issued in this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.10" data-order="|10|11|03|.10|" data-ref-path="10|11|03|.10" class="h__section">.10 Record Retention and Confidentiality.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A">A.</span> Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(1)">(1)</span> A provider shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(1)(a)">(a)</span> Retain and reproduce, upon request for a minimum of 6 years, records and reports required by the Department for the administration of services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(1)(b)">(b)</span> Be responsible for maintaining patient records for services that it provides in accordance with the approved Department retention schedule.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)">(2)</span> Records referred to in <a class="internal-link " href="/us/md/exec/comar/10.11.03.10#A(1)" title="">§A(1) of this regulation</a> include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(a)">(a)</span> Documentation of personal interviews;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(b)">(b)</span> Diagnosis and treatment recommendations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(c)">(c)</span> Records of professional visits and consultations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(d)">(d)</span> Consultant notes which shall be appropriately initialed or signed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(e)">(e)</span> Medical and laboratory data, including X-rays; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#A(2)(f)">(f)</span> Other data as may be required by applicable federal and State regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.10#B">B.</span> Confidentiality. A provider shall assure that the release of information from an eligible applicant's record is handled in accordance with Health-General Article, §§4-301—4-309, Annotated Code of Maryland, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.03.02" title="Chapter 02 Release of Confidential Information in the Maternal and Child Health Bureau">COMAR 10.03.02</a>, and other State and federal laws and regulations governing the confidentiality of records.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.11" data-order="|10|11|03|.11|" data-ref-path="10|11|03|.11" class="h__section">.11 General Conditions of Provider Participation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A">A.</span> A provider of services which are covered by the CMS Program shall comply with the following general requirements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A(1)">(1)</span> For fee for service reimbursement, be approved by Medical Assistance in writing as a Medical Assistance provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A(2)">(2)</span> For copay and deductible reimbursement, be a participating provider with the insurance plan purchased by the CMS Program for the family;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A(3)">(3)</span> Request preauthorization on the forms designated by the CMS Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A(4)">(4)</span> Adhere to administrative procedures that are established by the CMS Program for the specific treatment services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#A(5)">(5)</span> Maintain adequate records, including prescriptions, for a minimum of 6 years, and make them available upon request to the Department or the Department's designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#B">B.</span> The approval referenced in <a class="internal-link " href="/us/md/exec/comar/10.11.03.11#A(1)" title="">§A(1) of this regulation</a> shall specify, at a minimum, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#B(1)">(1)</span> Approved services which may be provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.11#B(2)">(2)</span> Duration of approval status.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.12" data-order="|10|11|03|.12|" data-ref-path="10|11|03|.12" class="h__section">.12 Conditions of Hospital Participation.</h3>
                <p>A hospital shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#A">A.</span> Comply with all relevant State and federal requirements related to the provision of health services and the receipt of funds;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#B">B.</span> Be licensed by the Department pursuant to the Hospital and Related Institutions subtitle, Health-General Article, Title 19, Subtitle 3, Annotated Code of Maryland, as a hospital, and be licensed, as may be required, by other applicable State and local laws;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#C">C.</span> Be accredited by the Joint Commission for Accreditation of Hospitals; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D">D.</span> Provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(1)">(1)</span> A physician specialist who is qualified in the area of need for which a recipient is hospitalized, and who shall supervise and be involved in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(1)(a)">(a)</span> The ongoing care of a child; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(1)(b)">(b)</span> Directing the development of the CMP and other appropriate care plans;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(2)">(2)</span> Pediatric physician supervision on a full-time or part-time basis to assist with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(2)(a)">(a)</span> Diagnostic evaluations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(2)(b)">(b)</span> Care planning and treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(2)(c)">(c)</span> Coordination with others involved in the development of the CMP;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(3)">(3)</span> Nursing services provided by a qualified nurse who has academic preparation and work experience in the care of children, including the specialty area of the condition to be treated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(4)">(4)</span> Surgical services, which shall have, as a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(4)(a)">(a)</span> Anesthesiologists trained and experienced in the management of pediatric patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(4)(b)">(b)</span> An appropriate recovery area which is staffed by personnel qualified in pediatrics and equipped with appropriate types and sizes of supplies and equipment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(5)">(5)</span> Available consultation in other specialty areas for the cases being treated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)">(6)</span> Other specialized support services, which shall include, but not be limited to, the following as appropriate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(a)">(a)</span> Audiology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(b)">(b)</span> Nutrition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(c)">(c)</span> Occupational therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(d)">(d)</span> Physical therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(e)">(e)</span> Psychiatry;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(f)">(f)</span> Psychology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(g)">(g)</span> Social work services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(6)(h)">(h)</span> Speech-language pathology;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(7)">(7)</span> An ongoing inpatient educational program for school-age children, which is approved by the State Department of Education, when long-term hospitalization is required;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(8)">(8)</span> Discharge planning procedures designed to maximize a child's recovery and rehabilitation, which shall include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(8)(a)">(a)</span> Predischarge planning activities to include all appropriate staff and representatives of other agencies involved or indicated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(8)(b)">(b)</span> Parental counseling regarding a child's medical and social needs after the child's release; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(8)(c)">(c)</span> Medical care planning resulting from input of the professionals concerned with a child's treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(9)">(9)</span> A discharge summary, which shall include as a minimum, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(9)(a)">(a)</span> Medications, primary and secondary diagnoses, hospital course, procedures performed, and complications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(9)(b)">(b)</span> Special equipment and other home care needs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(9)(c)">(c)</span> Follow-up plans including special transportation needs, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(10)">(10)</span> A separate area for a child, with provisions made for a parent or guardian to stay 24 hours, and nonrestrictive visiting hours for a parent or guardian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(11)">(11)</span> Suitable recreational facilities for children;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(12)">(12)</span> Facilities to isolate children with communicable diseases or other conditions requiring isolation or separation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(13)">(13)</span> Access to appropriate clinical laboratory facilities providing specialized diagnostic and treatment equipment, including radiological and nuclear medicine equipment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.12#D(14)">(14)</span> Outpatient facilities to provide follow-up care.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.13" data-order="|10|11|03|.13|" data-ref-path="10|11|03|.13" class="h__section">.13 General Billing Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#A">A.</span> A provider shall accept payment at the Medical Assistance rate as payment in full.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#B">B.</span> A provider shall submit:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#B(1)">(1)</span> Requests for payment on the form designated by the CMS Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#B(2)">(2)</span> Completed reports and attachments as requested by the CMS Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#C">C.</span> A provider may not bill the CMS Program for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#C(1)">(1)</span> Completion of forms and reports;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#C(2)">(2)</span> Broken or missed appointments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#C(3)">(3)</span> Professional services rendered by mail or telephone; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#C(4)">(4)</span> Services which are provided at no charge to the general public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#D">D.</span> The CMS Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#D(1)">(1)</span> Make no direct payment to the family;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#D(2)">(2)</span> Pay any claim for services provided on different dates and submitted on a single form, and only if it is received by the CMS Program within 12 months of the earliest date of service; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#D(3)">(3)</span> Pay a claim which is rejected for payment due to improper completion or incomplete information, only if it is properly completed, resubmitted, and received by the CMS Program within the original 12-month period or within 60 calendar days of rejection, whichever is later.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#E">E.</span> The CMS Program reserves the right to return to the provider, before payment, all:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#E(1)">(1)</span> Invoices not properly signed, completed, and accompanied by properly completed forms as required by the Department, to include any necessary preauthorization forms; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#E(2)">(2)</span> Claims not properly completed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.13#F">F.</span> If payment is denied by the CMS Program due to late billing, the provider may not seek payment from the child’s family.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.14" data-order="|10|11|03|.14|" data-ref-path="10|11|03|.14" class="h__section">.14 Billing Procedures for Physician Office Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#A">A.</span> A physician shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#A(1)">(1)</span> Comply with all procedures listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.13" title=".13 General Billing Procedures.">Regulation .13 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#A(2)">(2)</span> Charge the CMS Program the usual and customary charge to the general public for similar services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#A(3)">(3)</span> Bill the CMS Program as specified by the CMS Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B">B.</span> The CMS Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(1)">(1)</span> Use the fee schedule contained in the Maryland Medical Assistance Program’s Professional Services Provider Manual and Fee Schedule, which is incorporated by reference in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(2)">(2)</span> Pay for covered services that are the lower of the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(2)(a)">(a)</span> Physician’s customary charge; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(2)(b)">(b)</span> Department's fee schedule;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(3)">(3)</span> Reimburse the provider for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(3)(a)">(a)</span> Dispensed drugs at rates established by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">COMAR 10.09.03</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#B(3)(b)">(b)</span> Injectable drugs at rates promulgated by the Professional Services Provider Manual and Fee Schedule referenced in <a class="internal-link " href="/us/md/exec/comar/10.11.03.14#B(1)" title="">§B(1) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.14#C">C.</span> The CMS Program reserves the right to negotiate and establish a different fee for the physician or the group of physicians under contract to a hospital to provide services when a portion of the cost of the contract is paid as the hospital’s cost.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.15" data-order="|10|11|03|.15|" data-ref-path="10|11|03|.15" class="h__section">.15 Billing Procedures for Medically Necessary Dental Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.15#A">A.</span> A dentist shall comply with all procedures listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.13" title=".13 General Billing Procedures.">Regulation .13 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.15#B">B.</span> The CMS Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.15#B(1)">(1)</span> Cover approved diagnostic, restorative, and preventive treatment as described in the CMP; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.15#B(2)">(2)</span> Preauthorize estimates of costs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.16" data-order="|10|11|03|.16|" data-ref-path="10|11|03|.16" class="h__section">.16 Billing Procedures for Orthodontic Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#A">A.</span> An orthodontist shall comply with all procedures listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.13" title=".13 General Billing Procedures.">Regulation .13 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#B">B.</span> The CMS Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#B(1)">(1)</span> Reimburse for correction of the full permanent dentition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#B(2)">(2)</span> Give special consideration to services for children with malocclusions in the mixed dentition associated with cleft palates or other craniofacial deformities</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#C">C.</span> The CMS Program may not reimburse for preliminary visits to the orthodontist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.16#D">D.</span> The provider may not charge the patient, parent, or guardian for orthodontic treatment, including retention visits.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.17" data-order="|10|11|03|.17|" data-ref-path="10|11|03|.17" class="h__section">.17 Billing Procedures for Durable Goods and Equipment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#A">A.</span> The durable goods and equipment providers shall comply with all procedures listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.13" title=".13 General Billing Procedures.">Regulation .13 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#B">B.</span> A provider shall charge the CMS Program the usual and customary charge to the general public for similar durable goods and equipment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#C">C.</span> The CMS Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#C(1)">(1)</span> Pay for covered services which are the least expensive, except for those described in <a class="internal-link " href="/us/md/exec/comar/10.11.03.17#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#C(2)">(2)</span> Determine, based upon expected duration of medical needs, whether durable medical equipment will be purchased or rented; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#C(3)">(3)</span> Pay for repairs to purchased durable medical equipment and disposable medical supplies according to the Medical Assistance reimbursement rate for charges.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.17#D">D.</span> The ownership of equipment shall remain with the CMS Program and shall be recovered at the option of the CMS Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.18" data-order="|10|11|03|.18|" data-ref-path="10|11|03|.18" class="h__section">.18 Billing Procedures for Pharmacy Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#A">A.</span> A pharmacy provider shall comply with all procedures listed in <a class="internal-link " href="/us/md/exec/comar/10.11.03.13" title=".13 General Billing Procedures.">Regulation .13 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#B">B.</span> A pharmacy provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#B(1)">(1)</span> Upon request, produce records to verify any charge to the CMS Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#B(2)">(2)</span> Charge the CMS Program the usual and customary charge to the general public for similar prescriptions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#C">C.</span> Determination of allowable cost for multiple source drugs designated by the Centers for Medicare and Medicaid Services of the Department of Health and Human Services or for each drug listed in the formulary allowable cost shall be the lowest of the maximum allowable cost.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#D">D.</span> Payment for covered services to a pharmacy shall be made as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#D(1)">(1)</span> Payment for formulary drug preparation shall be the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#D(1)(a)">(a)</span> Least expensive available; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#D(1)(b)">(b)</span> Allowable cost according to the State Title XIX Agency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.18#D(2)">(2)</span> Payment for over-the-counter drugs is not covered except in extenuating circumstances at the discretion of the CMS Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.19" data-order="|10|11|03|.19|" data-ref-path="10|11|03|.19" class="h__section">.19 Billing Procedures for Hospitals.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A">A.</span> All hospitals shall comply with the following procedures:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(1)">(1)</span> Hospitals located in Maryland that participate in the CMS Program shall charge and be reimbursed at the Medical Assistance rates approved by the Health Services Cost Review Commission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(2)">(2)</span> The CMS Program shall pay room and board charges for the day of admission, and may not pay room and board charges for the day of discharge from the hospital;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(3)">(3)</span> The CMS Program may not reimburse for the services of a hospital’s salaried or contractual physicians as a separate line item;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(4)">(4)</span> The contractual physicians' salaries shall be included in the room and board rate or the appropriate ancillary service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(5)">(5)</span> When a patient is discharged from one general hospital and is admitted to another general hospital and 24 hours have not elapsed between the discharge and admission, the CMS Program shall pay only for those medically necessary days, with the payment for the patient’s hospitalization being apportioned between the two hospitals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(6)">(6)</span> The CMS Program shall be contacted regarding exceptions or extenuating circumstances relating to admissions and discharges if the patient returns the same day before the hospital patient count;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(7)">(7)</span> All nonemergency inpatient hospital admissions require preadmission approval by the CMS Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(8)">(8)</span> Authorization is required by the CMS Program or its designee for more than one preoperative inpatient day; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#A(9)">(9)</span> The CMS Program may not reimburse for hospital admissions where a child has been discharged due to cancellation of planned surgery or treatment. The hospital may not bill the family for these charges.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#B">B.</span> In addition, all out-of-state providers shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#B(1)">(1)</span> Participate in Title XVIII of the Social Security Act;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#B(2)">(2)</span> Have in effect a utilization review plan applicable to all patients who receive Medical Assistance under Title XIX of the Social Security Act and which meets the requirements of the Social Security Act, §186(k), unless a waiver has been granted by the Secretary of Health and Human Services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#B(3)">(3)</span> Meet additional conditions for participation and comply with the requirements specified in <a class="internal-link " href="/us/md/exec/comar/10.11.03.11" title=".11 General Conditions of Provider Participation.">Regulation .11 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.19#C">C.</span> All hospital services shall be reimbursed at the Medical Assistance rate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.20" data-order="|10|11|03|.20|" data-ref-path="10|11|03|.20" class="h__section">.20 Cause for Suspension or Removal and Imposition of Sanctions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#A">A.</span> If the Department determines that a provider, vendor, agent or employee of the provider, vendor, or a person with an ownership interest in the provider or vendor has failed to comply with these regulations, or applicable federal or State laws or regulations, the Department may initiate one or more of the following actions against the responsible party:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#A(1)">(1)</span> Suspension from the CMS Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#A(2)">(2)</span> Withholding of payment from the CMS Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#A(3)">(3)</span> Removal from the CMS Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#A(4)">(4)</span> Disqualification from future participation in the CMS Program, either as a provider or vendor providing services for which CMS Program payment may be claimed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.03.20#B">B.</span> If the Secretary of the United States Department of Health and Human Services suspends or removes a provider from participation in Medicare or Medical Assistance, the Department shall take similar action.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.03.21" data-order="|10|11|03|.21|" data-ref-path="10|11|03|.21" class="h__section">.21 Funding Availability.</h3>
                <p>Payment under this chapter is contingent on the availability of funds in accordance with State Finance and Procurement Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-234" title="">7-234</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-235" title="">7-235</a>, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.04" data-order="|10|11|04|" data-ref-path="10|11|04" class="h__chapter">Chapter 04 Lead Poisoning Screening Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: May 12, 2003 (30:9 Md. R. 614)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.02#B" title="">Regulation .02B</a> amended as an emergency provision effective September 1, 2003 (30:20 Md. R. 1445); amended permanently effective December 22, 2003 (30:25 Md. R. 1845)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.02#B" title="">Regulation .02B</a> amended effective March 28, 2016 (43:6 Md. R. 407); December 25, 2023 (50:25 Md. R. 1087)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.03" title=".03 Administration of Lead Exposure Risk Questionnaire.">Regulation .03</a> amended as an emergency provision effective September 1, 2003 (30:20 Md. R. 1445); amended permanently effective December 22, 2003 (30:25 Md. R. 1845)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.04" title=".04 Blood Tests for Lead Poisoning.">Regulation .04</a> amended as an emergency provision effective September 1, 2003 (30:20 Md. R. 1445); amended permanently effective December 22, 2003 (30:25 Md. R. 1845)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.04" title=".04 Blood Tests for Lead Poisoning.">Regulation .04</a> amended effective March 16, 2015 (42:5 Md. R. 486); March 28, 2016 (43:6 Md. R. 407); December 25, 2023 (50:25 Md. R. 1087)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.05" title=".05 Documentation Requirements on Entry into a Prekindergarten Program, Kindergarten Program, or First Grade.">Regulation .05</a> amended as an emergency provision effective September 1, 2003 (30:20 Md. R. 1445); amended permanently effective December 22, 2003 (30:25 Md. R. 1845)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.05" title=".05 Documentation Requirements on Entry into a Prekindergarten Program, Kindergarten Program, or First Grade.">Regulation .05</a> amended effective March 28, 2016 (43:6 Md. R. 407)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.06" title=".06 Blood Lead Analysis Reporting Requirements.">Regulation .06</a> amended effective March 28, 2016 (43:6 Md. R. 407)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.04.06#A" title="">Regulation .06A</a> amended as an emergency provision effective September 1, 2003 (30:20 Md. R. 1445); amended permanently effective December 22, 2003 (30:25 Md. R. 1845)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=ged&amp;section=7-403" title="">Education Article, §7-403</a>; <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=6-303" title="">Environment Article, §6-303</a>; and Health-General Article, §18-106; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.04.01" data-order="|10|11|04|.01|" data-ref-path="10|11|04|.01" class="h__section">.01 Purpose.</h3>
                <p>The purpose of this chapter is to set forth requirements for conducting lead poisoning risk assessments, blood tests for lead poisoning of minor children, and the reporting of blood lead analysis in accordance with applicable State law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.04.02" data-order="|10|11|04|.02|" data-ref-path="10|11|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(1)">(1)</span> “Administer a blood test for lead poisoning” means to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(1)(a)">(a)</span> Draw a blood specimen, by either venous or capillary methodology, and:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(1)(a)(i)">(i)</span> Send the specimen to a medical laboratory for blood lead analysis; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(1)(a)(ii)">(ii)</span> Conduct a blood lead analysis at a health care provider's office subject to licensing, certification, and approval by the Laboratories Administration of the Department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(1)(b)">(b)</span> Order a blood specimen to be drawn by a third-party health care provider, by either venous or capillary methodology, and sent to a medical laboratory for blood lead analysis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(2)">(2)</span> “At-risk area” means any geographic area within the State that has been designated by the Department as at-risk for lead exposure in the 2015 Targeting Plan for Areas at Risk for Childhood Lead Poisoning.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(3)">(3)</span> “Blood lead analysis” means the analysis and determination by a medical laboratory of the blood lead level in a blood specimen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(3-1)">(3-1)</span> “Blood lead reference value” means a blood lead level of 3.5 micrograms per deciliter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(4)">(4)</span> “CDC” means the federal Centers for Disease Control and Prevention.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(5)">(5)</span> “Child” means an individual younger than 18 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(6)">(6)</span> Repealed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(7)">(7)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(8)">(8)</span> Repealed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(9)">(9)</span> "EPSDT" means the Early and Periodic Screening Diagnosis and Treatment program governed by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.23" title="Chapter 23 Early and Periodic Screening, Diagnosis and Treatment (EPSDT) Services">COMAR 10.09.23</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(10)">(10)</span> "Health care provider" means a person who is licensed, certified, or otherwise authorized to provide health care services under the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(11)">(11)</span> Repealed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(12)">(12)</span> “Immunization registry” means an immunization registry established and maintained by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(13)">(13)</span> “Lead exposure risk questionnaire” means the set of questions used to determine an individual's risk for lead exposure and lead poisoning, as approved by the Department and based on the recommendations from the CDC.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(14)">(14)</span> Repealed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(15)">(15)</span> “Medical laboratory” means a licensed medical laboratory as defined by Health-General Article, §17-201(b), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(16)">(16)</span> “Nonprimary care” means health care that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(16)(a)">(a)</span> Is given or recommended by a health care provider that is not the individual's primary care provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(16)(b)">(b)</span> Includes but is not limited to episodic health care for acute illness or injury or health care that is given in an emergency room or other urgent care setting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)">(17)</span> Prekindergarten Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(a)">(a)</span> “Prekindergarten program” means a public educational or public early intervention program that enrolls or serves children below the level of kindergarten.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)">(b)</span> “Prekindergarten program” includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(i)">(i)</span> Programs that operate within a school and those that operate outside of a school;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(ii)">(ii)</span> Preschool special education programs governed by COMAR 13A.05.01;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(iii)">(iii)</span> Extended Elementary Education Programs governed by COMAR 13A.06.02.01;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(iv)">(iv)</span> Local Infant and Toddler Programs as defined in COMAR 13A.13.01;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(v)">(v)</span> Head Start and Early Head Start Programs as authorized under the Head Start Act, 42 U.S.C. §9801 et seq.;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(vi)">(vi)</span> Judith P. Hoyer Early Child Care and Education Centers established by Education Article, 5-217, Annotated Code of Maryland; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(17)(b)(vii)">(vii)</span> Any other educational or early intervention program as determined by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)">(18)</span> “Primary care” means health care that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(a)">(a)</span> Is continuous, comprehensive and coordinated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(b)">(b)</span> Emphasizes prevention of illness and injury; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)">(c)</span> Includes but is not limited to the following services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(i)">(i)</span> Age appropriate screenings;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(ii)">(ii)</span> Diagnosis and treatment of acute and chronic disorders;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(iii)">(iii)</span> Growth and developmental assessments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(iv)">(iv)</span> Health care supervision;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(v)">(v)</span> Immunizations;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(vi)">(vi)</span> Patient and parent health and psychosocial counseling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(vii)">(vii)</span> Physical examinations; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(18)(c)(viii)">(viii)</span> Referrals to specialty health care providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(19)">(19)</span> “Primary care provider” means a health care provider that provides primary care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(20)">(20)</span> “Targeting Plan” means the 2015 Targeting Plan for Areas at Risk for Childhood Lead Poisoning developed by the Department that includes but is not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(20)(a)">(a)</span> Methodology for determining levels of risk for childhood lead poisoning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(20)(b)">(b)</span> Maps of the State designating at-risk areas;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(20)(c)">(c)</span> Zip code and census tract lists indicating each zip code and census tract's designated level of risk; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(20)(d)">(d)</span> Recommendations regarding the prevention of childhood lead poisoning.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(21)">(21)</span> “12-month visit” means a well-child evaluation by a health care provider that occurs when a child is between 12 months old and 14 months old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(22)">(22)</span> “24-month visit” means a well-child evaluation by a health care provider that occurs when the child is between 24 months old and 26 months old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(23)">(23)</span> “Well-child evaluation” means a periodic primary care assessment of a child by a primary care provider in accordance with the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(23)(a)">(a)</span> American Academy of Pediatrics' guidelines; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.02#B(23)(b)">(b)</span> Periodicity schedule established under EPSDT requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.04.03" data-order="|10|11|04|.03|" data-ref-path="10|11|04|.03" class="h__section">.03 Administration of Lead Exposure Risk Questionnaire.</h3>
                <p>A primary care provider for a child shall complete a lead exposure risk questionnaire:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.03#A">A.</span> During the 12-month visit and again during the 24-month visit if the child does not reside in an at-risk area;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.03#B">B.</span> If the child does not reside in an at-risk area and is 24 months old or older and younger than 6 years old, and the provider does not have documentation that a blood test for lead poisoning or a lead exposure risk questionnaire has been previously administered to, or completed on behalf of, the child;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.03#C">C.</span> At each well-child check for a child who is 6 months old or older and younger than 6 years old, and resides in an at-risk area; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.03#D">D.</span> In accordance with the EPSDT requirements for a child insured under the Maryland Medicaid program regardless of the child's area of residence.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.04.04" data-order="|10|11|04|.04|" data-ref-path="10|11|04|.04" class="h__section">.04 Blood Tests for Lead Poisoning.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#A">A.</span> A primary care provider for a child who resides, or who is known to have previously resided, in an at-risk area shall administer a blood test for lead poisoning during the 12-month visit and again during the 24-month visit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#B">B.</span> A primary care provider for a child who is 24 months old or older and younger than 6 years old who resides, or who is known to have previously resided, in an at-risk area as defined in the 2015 Targeting Plan for Areas at Risk for Childhood Lead Poisoning, shall administer a blood test for lead poisoning if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#B(1)">(1)</span> Child has not previously received a blood test for lead poisoning;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#B(2)">(2)</span> Child's parent or guardian fails to provide documentation that the child has previously received a blood test for lead poisoning; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#B(3)">(3)</span> Provider is unable to obtain the results of a previous blood lead analysis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#C">C.</span> A primary care provider for a child shall administer a blood test for lead poisoning to a child if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#C(1)">(1)</span> An affirmative answer, or a response indicating that the parent or guardian does not know the answer, is given for any question on a lead exposure risk questionnaire that is completed for the child pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.03" title=".03 Administration of Lead Exposure Risk Questionnaire.">Regulation .03 of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#C(2)">(2)</span> The child's parent or guardian requests that the child receive a blood test for lead poisoning regardless of the child's age or area of residence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#D">D.</span> If a child is insured under Maryland's Medicaid program, the child's primary care provider shall administer a blood test for lead poisoning to the child at the 12-month visit and again at the 24-month visit in accordance with EPSDT requirements regardless of the child's area of residence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#E">E.</span> A primary care provider shall administer a blood test for lead poisoning, by venous methodology, if the results of a capillary blood test for lead poisoning indicate a blood lead level that exceeds the blood lead reference level.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#F">F.</span> For each blood test for lead poisoning administered by a health care provider, the provider shall provide on the lab order form the information for blood lead reporting that is required under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=6-303" title="">Environment Article, §6-303, Annotated Code of Maryland</a>, to the medical laboratory that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#F(1)">(1)</span> Draws the blood specimen; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#F(2)">(2)</span> Performs the blood lead analysis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#G">G.</span> Physician offices and other point-of-care laboratories shall comply with the requirements under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02#B(36)" title="">COMAR 10.10.03.02B(36)</a> and C.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H">H.</span> Bona Fide Religious Beliefs — At Risk.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(1)">(1)</span> If the parent or guardian of a child refuses to consent to a blood test for lead poisoning due to the parent or guardian's stated bona fide religious beliefs and practices, a primary care provider shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(1)(a)">(a)</span> Counsel the parent or guardian that the blood test for lead poisoning is required by law due to the fact that their child is at risk for having a blood lead level that exceeds the blood lead reference level; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(1)(b)">(b)</span> Complete a lead exposure risk questionnaire for the child in the presence of the child and the child's parent or guardian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(2)">(2)</span> If an affirmative response to the questionnaire under <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#H(1)(b)" title="">§H(1)(b) of this regulation</a>, or a response indicating that the parent or guardian does not know the answer, is entered for any question on the lead exposure risk questionnaire for the child, the provider shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(2)(a)">(a)</span> Further counsel the parent or guardian regarding the risks of lead poisoning, including the potential physical, behavioral, developmental, and intellectual effects, and again request the parent or guardian to consent to a blood test for lead poisoning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(2)(b)">(b)</span> Document in the child's medical record any continued refusal by the parent or guardian to consent to a blood test for lead poisoning despite counseling, and the grounds for the parent or guardian's refusal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(2)(c)">(c)</span> Write and sign an order for a blood test for lead poisoning on a medical laboratory order form; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(2)(d)">(d)</span> Give the child's parent or guardian the completed order for the medical laboratory to draw a blood specimen for blood lead analysis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(3)">(3)</span> If all the responses to the lead exposure risk questionnaire are negative, the provider shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(3)(a)">(a)</span> Follow procedures set forth in <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#H(2)(b)" title="">§H(2)(b) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#H(3)(b)">(b)</span> Complete a form issued by the Department indicating that the questionnaire was completed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#I">I.</span> Repealed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#J">J.</span> This regulation does not limit the duties of the child's health care provider, with respect to any child who resides or has previously resided in an at-risk area, under any other provision of the law.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.04#K">K.</span> A health care provider giving nonprimary care to a child may, but is not required to, administer a blood test for lead poisoning, even if a blood test for lead poisoning is not medically indicated.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.04.05" data-order="|10|11|04|.05|" data-ref-path="10|11|04|.05" class="h__section">.05 Documentation Requirements on Entry into a Prekindergarten Program, Kindergarten Program, or First Grade.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#A">A.</span> The parent or guardian of a child who currently resides, or has previously resided, in an at-risk area shall provide to the administrator of the child’s school or program, or the administrator’s designee, certified documentation of the child’s blood lead analysis, as specified in <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#G" title="">§G of this regulation</a>, on first entry into a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#A(1)">(1)</span> Maryland public prekindergarten program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#A(2)">(2)</span> Maryland public school system at the level of prekindergarten, kindergarten or first grade.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#B">B.</span> An electronic report of the child’s blood lead analysis from a health care provider to the administrator of the child’s school or program, or the administrator’s designee, may serve as an acceptable alternative to the documentation required in <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#C">C.</span> A health care provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#C(1)">(1)</span> Document and certify by signature the dates of the blood lead analysis administered to a child pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#A" title="">Regulation .04A of this chapter</a> on a form developed by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#C(2)">(2)</span> Upon request by the child’s public school or program administrator, or the administrator’s designee, for a child who resides or has previously resided in an at-risk area, provide to the school or program the certified documentation of the child’s blood lead analysis, as specified in <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#G" title="">§G of this regulation</a>, in order to facilitate the Department’s public health surveillance activities relating to lead poisoning.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#D">D.</span> The child’s parent or guardian shall provide certified documentation of the child’s blood lead analysis, as specified in <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#G" title="">§G of this regulation</a>, administered in connection with the 12-month visit and 24-month visit to a Maryland public prekindergarten program not later than:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#D(1)">(1)</span> 20 calendar days from the 12-month visit or 24-month visit; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#D(2)">(2)</span> 20 calendar days from first entry into the program or system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#E">E.</span> Pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#A" title="">Regulation .04A of this chapter</a>, if the child’s first blood test for lead poisoning was administered after the child is 24 months old, then only certified documentation of the most recent blood lead analysis is required to be reported pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#F">F.</span> Pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#A" title="">Regulation .04A of this chapter</a>, if a child has more than two blood tests for lead poisoning done between the ages of 12 months and 24 months, then only certified documentation of the two most recent blood lead analyses shall be reported.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G">G.</span> The information sent to or received by a program or school pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#A" title="">§A of this regulation</a> shall be recorded and certified by a health care provider’s signature on a form issued by the Department that includes the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G(1)">(1)</span> Name of the child;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G(2)">(2)</span> Date and result of the blood lead analysis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G(3)">(3)</span> The signature of the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G(3)(a)">(a)</span> Child's primary care provider or designee; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#G(3)(b)">(b)</span> School health professional or designee that transcribed the information onto the form issued by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#H">H.</span> If a child is not required to receive a blood test for lead poisoning pursuant to Regulation .04A or B of this chapter, then the child's parent or guardian shall provide to the administrator of the child's school or program, or the administrator's designee, on a form issued by the Department, documentation that the child does not reside and has never resided in an at-risk area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#I">I.</span> If a parent or guardian does not consent to a blood test for lead poisoning pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.04#H" title="">Regulation .04H of this chapter</a>, the child’s parent or guardian shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#I(1)">(1)</span> Take their child to a primary care provider for the provider to complete a lead poisoning risk assessment questionnaire; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#I(2)">(2)</span> Submit to the administrator of the child's school or program, or the administrator's designee, a written, signed statement of exemption on a form issued by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#J">J.</span> Notice Required.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#J(1)">(1)</span> The program or school shall give notice in accordance with <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#J(2)" title="">§J(2) of this regulation</a> to the parent or guardian of a child who resides or has resided in an at-risk area who does not provide:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#J(1)(a)">(a)</span> The certified documentation of the child’s blood lead analysis, as specified in <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#G" title="">§G of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#J(1)(b)">(b)</span> A signed statement of exemption.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.04.05#J(2)">(2)</span> The notice required under this section shall state that the parent or guardian is required by law to provide the information under <a class="internal-link " href="/us/md/exec/comar/10.11.04.05#J(1)" title="">§J(1) of this regulation</a> at the time of enrollment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.04.06" data-order="|10|11|04|.06|" data-ref-path="10|11|04|.06" class="h__section">.06 Blood Lead Analysis Reporting Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.06#A">A.</span> Notwithstanding <a class="internal-link " href="/us/md/exec/comar/10.11.04.06#B" title="">§B of this regulation</a>, a medical laboratory shall report, to the Department of the Environment, the information required under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=6-303" title="">Environment Article, §6-303, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.06#B">B.</span> A medical laboratory that performs blood lead analysis shall report the results of all blood tests for lead poisoning, performed pursuant to <a class="internal-link " href="/us/md/exec/comar/10.11.04.04" title=".04 Blood Tests for Lead Poisoning.">Regulation .04 of this chapter</a> for a child who resides in Baltimore City, to the Commissioner of the Baltimore City Health Department in accordance with Article-Health, §4-607, Baltimore City Revised Code.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.06#C">C.</span> The Commissioner of the Baltimore City Health Department may report the information received under <a class="internal-link " href="/us/md/exec/comar/10.11.04.06#B" title="">§B of this regulation</a> to the Baltimore Immunization Registry Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.06#D">D.</span> The Department may report the results of blood lead analysis to an immunization registry developed by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.04.06#E">E.</span> The Department of the Environment may report the results of blood lead analysis to an immunization registry developed by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.05" data-order="|10|11|05|" data-ref-path="10|11|05" class="h__chapter">Chapter 05 Child Death Review Case Reporting System</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 6, 2009 (36:7 Md R. 524)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b) and 5-704, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.05.01" data-order="|10|11|05|.01|" data-ref-path="10|11|05|.01" class="h__section">.01 Purpose.</h3>
                <p>The purpose of this chapter is to clarify the authority of State and local child fatality review teams in Maryland to participate in certain national child death review case reporting systems as a means to enhance the CFR teams' ability to more effectively carry out its purpose of:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.01#A">A.</span> Developing an understanding of the causes and incidence of child deaths;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.01#B">B.</span> Developing plans for and implementing changes within the agencies represented on the child fatality review teams to prevent child deaths; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.01#C">C.</span> Advising the Governor, the General Assembly, and the public on changes to law, policy, and practice to prevent child deaths.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.02" data-order="|10|11|05|.02|" data-ref-path="10|11|05|.02" class="h__section">.02 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.02#A">A.</span> This chapter controls the drafting and implementation of data use agreements between the State child fatality review team and other public or private organizations or entities in order to assure that Maryland's State and local child fatality review teams are able to participate in and utilize recognized, appropriate national child death review case reporting systems in a secure manner that comports with applicable laws governing the confidentiality of child death information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.02#B">B.</span> This chapter governs the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.02#B(1)">(1)</span> Maintenance of confidential child death review case data;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.02#B(2)">(2)</span> Participation of State and local child fatality review teams in national child death review reporting systems; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.02#B(3)">(3)</span> Aggregation and reporting of de-identified child death data in the administration of Health-General Article, Title 5, Subtitle 7, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.03" data-order="|10|11|05|.03|" data-ref-path="10|11|05|.03" class="h__section">.03 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(1)">(1)</span> "Child death review (CDR) case reporting system" means a national standardized, web-based reporting system for the confidential collection, analysis, aggregation, and reporting of child death data that is maintained and operated by a national center for child death review (NCCDR).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(2)">(2)</span> "Data use agreement" means a contract between the Department and a NCCDR that establishes the terms and conditions for the State and local CFR teams' participation in a child death review case reporting system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(3)">(3)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(4)">(4)</span> "Local child fatality review (CFR) team" means a multidisciplinary and multiagency review team established by a county under Health-General Article, §5-705, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)">(5)</span> "National center for child death review (NCCDR)" means a public, private, nonprofit, or governmental organization or entity that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)(a)">(a)</span> Funded or otherwise recognized by the United States Department of Health and Human Services (DHHS); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)(b)">(b)</span> Responsible for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)(b)(i)">(i)</span> Developing a CDR case reporting system;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)(b)(ii)">(ii)</span> Training and serving as a liaison to State agencies participating in the system; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(5)(b)(iii)">(iii)</span> Disseminating national child death review data generated by the system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.03#B(6)">(6)</span> "State Child Fatality Review (CFR) Team" means the State-level multidisciplinary and multiagency review team established under Health-General Article, §5-702, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.04" data-order="|10|11|05|.04|" data-ref-path="10|11|05|.04" class="h__section">.04 Data Use Agreement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.04#A">A.</span> The Department may enter into a data use agreement with a NCCDR to participate in the NCCDR's case reporting system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.04#B">B.</span> The purpose of the data use agreement is to establish the terms and conditions for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.04#B(1)">(1)</span> The confidential submission, collection, storage, and analysis of data obtained from the child death case reviews submitted by Maryland's State and local CFR teams; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.04#B(2)">(2)</span> The reporting, aggregation, and dissemination of de-identified child death review data generated by the CDR case reporting system.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.05" data-order="|10|11|05|.05|" data-ref-path="10|11|05|.05" class="h__section">.05 National Center for Child Death Review's Duties.</h3>
                <p>The data use agreement with the NCCDR shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.05#A">A.</span> Assure that the State and local CFR teams have full access to and use of the CDR reporting system for the purposes of collecting, analyzing, aggregating, and reporting on child death review data;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.05#B">B.</span> Facilitate the comparison of aggregate, de-identified child death data within and among the State and local CFR teams; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.05#C">C.</span> Require that the NCCDR acts as a fiduciary agent of the State and local CFR teams in carrying out their responsibilities under this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.06" data-order="|10|11|05|.06|" data-ref-path="10|11|05|.06" class="h__section">.06 Electronic Data Transmittal.</h3>
                <p>Staff of the State or local CFR team shall first de-identify or remove information which would allow identification of an individual from any CFR team reports filed with, or information electronically transmitted by staff to, the NCCDR.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.07" data-order="|10|11|05|.07|" data-ref-path="10|11|05|.07" class="h__section">.07 Confidentiality of Data.</h3>
                <p>If any personally identifying child fatality review information or record is acquired by the NCCDR or its staff, that information or record is confidential and subject to the same confidentiality and discovery protections set forth in Health-General Article, §5-709, Annotated Code of Maryland, that apply to the State and local CFR teams.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.05.08" data-order="|10|11|05|.08|" data-ref-path="10|11|05|.08" class="h__section">.08 Terms and Construction of a Data Use Agreement.</h3>
                <p>Any data use agreement entered into by the State CFR Team and a NCCDR shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.08#A">A.</span> Incorporate by reference and be construed in accordance with the provisions of Health-General Article, Title 5, Subtitle 7, Annotated Code of Maryland, and this chapter; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.05.08#B">B.</span> Be coexecuted by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.08#B(1)">(1)</span> The Secretary or the Secretary's designee; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.05.08#B(2)">(2)</span> The chairperson of the State CFR Team.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.06" data-order="|10|11|06|" data-ref-path="10|11|06" class="h__chapter">Chapter 06 Morbidity, Mortality, and Quality Review Committee — Pregnancy and Childhood</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 21, 2009 (36:19 Md R. 1436)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.02#B" title="">Regulation .02B</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.03" title=".03 Incorporation by Reference.">Regulation .03</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.05" title=".05 Membership.">Regulation .05</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.05#B" title="">Regulation .05B</a> amended effective March 14, 2016 (43:5 Md. R. 385)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.06" title=".06 Committee Duties.">Regulation .06</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.07" title=".07 Local Teams — Establishment and Purpose.">Regulation .07</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.08" title=".08 FIMR Teams — Membership.">Regulation .08</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.09" title=".09 MMQR Teams — General.">Regulation .09</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.10" title=".10 Types of Committee Reviews.">Regulation .10</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.11" title=".11 Access to Records and Information.">Regulation .11</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.12" title=".12 Meetings.">Regulation .12</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.11.06.13" title=".13 Confidentiality of Records and Information.">Regulation .13</a> amended effective April 23, 2018 (45:8 Md. R. 421)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §18-107, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.06.01" data-order="|10|11|06|.01|" data-ref-path="10|11|06|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not apply to the review of a fetal death that is the result of a voluntary or therapeutic termination of pregnancy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.02" data-order="|10|11|06|.02|" data-ref-path="10|11|06|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(1)">(1)</span> "Committee" means the Morbidity, Mortality, and Quality Review Committee established within the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(2)">(2)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(3)">(3)</span> "Jurisdiction" means a political subdivision of the State, including the 23 counties and Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(4)">(4)</span> "Early childhood" means the period in which an individual is younger than 6 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(5)">(5)</span> “Fetal and infant mortality review (FIMR) team” means a local multidisciplinary and multiagency morbidity, mortality, and quality review team established by a health officer or health officers of a group of jurisdictions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(6)">(6)</span> "Fetal death" has the meaning stated in Health-General Article, §4-201, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(7)">(7)</span> "Health care provider" has the meaning stated in Health-General Article, §5-601, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(8)">(8)</span> "Health officer" has the meaning stated in Health-General Article, §1-101, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(9)">(9)</span> "Infant death" means death occurring to an individual who is younger than 1 year old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(10)">(10)</span> "Maryland Perinatal System Standards" means the hospital perinatal program standards established by the Perinatal Clinical Advisory Committee of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(11)">(11)</span> “Morbidity, mortality, and quality review (MMQR) team” means a local multidisciplinary and multiagency morbidity, mortality, and quality review team, or entity established to review cases associated with pregnancy, childbirth, infancy, or early childhood in order to make improvements in systems of care, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(11)(a)">(a)</span> A fetal and infant mortality review team; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(11)(b)">(b)</span> Another multidisciplinary and multiagency review team or other entity established for a jurisdiction that addresses an aspect of morbidity, mortality, or quality of care associated with pregnancy, childbirth, infancy, or early childhood.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(12)">(12)</span> “Perinatal center” means a hospital that offers obstetric or neonatal services, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(13)">(13)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.02#B(14)">(14)</span> "Transport" means the transfer of a patient to another health care facility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.03" data-order="|10|11|06|.03|" data-ref-path="10|11|06|.03" class="h__section">.03 Incorporation by Reference.</h3>
                <p>The Maryland Perinatal System Standards (Perinatal Clinical Advisory Committee, June 2014) is incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.04" data-order="|10|11|06|.04|" data-ref-path="10|11|06|.04" class="h__section">.04 Morbidity, Mortality, and Quality Review Committee.</h3>
                <p>There is a Morbidity, Mortality, and Quality Review Committee established within the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.05" data-order="|10|11|06|.05|" data-ref-path="10|11|06|.05" class="h__section">.05 Membership.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#A">A.</span> The Committee shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#A(1)">(1)</span> A State-level multidisciplinary and multiagency review Committee within the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#A(2)">(2)</span> Composed of at least 26 members as described in §§B and C of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B">B.</span> Ex Officio Members. The Committee shall include the following ex officio members or their designees:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(1)">(1)</span> The Secretary of the Maryland Department of Health;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(2)">(2)</span> The Secretary of Human Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(3)">(3)</span> The Deputy Secretary of the Health Care Financing Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(4)">(4)</span> The Director of the Vital Statistics Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(5)">(5)</span> The Director of the Prevention and Health Promotion Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(6)">(6)</span> The Director of the Behavioral Health Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(7)">(7)</span> The Director of the Maternal and Child Health Bureau;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(8)">(8)</span> The Chief Medical Examiner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(9)">(9)</span> The Director of the Office of Minority Health and Health Disparities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(10)">(10)</span> The Director of the Office of Health Care Quality;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(11)">(11)</span> The Executive Director of the Maryland Health Care Commission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(12)">(12)</span> The Executive Director of the Maryland Institute for Emergency Medical Services Systems;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(13)">(13)</span> The Executive Director of the Medical and Chirurgical Faculty of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(14)">(14)</span> The President of the Maryland Hospital Association;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(15)">(15)</span> The President of the Maryland Chapter of the American Academy of Pediatrics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(16)">(16)</span> The Chair of the Maryland Section of the American College of Obstetricians and Gynecologists;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(17)">(17)</span> One representative from the University of Maryland School of Medicine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(18)">(18)</span> One representative from the Johns Hopkins School of Medicine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(19)">(19)</span> Three representatives from the Maryland Association of County Health Officers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(20)">(20)</span> The Chair of the Maryland State Child Fatality Review Team; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#B(21)">(21)</span> The Chair of the Maryland Maternal Mortality Review Committee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#C">C.</span> Appointed Members.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#C(1)">(1)</span> The Secretary shall appoint one Committee member that is a certified nurse midwife from a list of qualified individuals submitted by professional nursing organizations that represent licensed registered nurses in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#C(2)">(2)</span> The Secretary may appoint up to five other Committee members and may appoint additional members who are individuals with an interest and expertise in pregnancy, childbirth, infancy, or early childhood or other related disciplines as considered necessary by the Secretary to carry out the Committee’s responsibilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#C(3)">(3)</span> Appointed Committee members shall serve at the pleasure of the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#D">D.</span> Designation of Representatives. An ex officio member described under <a class="internal-link " href="/us/md/exec/comar/10.11.06.05#B" title="">§B of this regulation</a> may designate another individual to represent the member on the Committee from the member’s:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#D(1)">(1)</span> Agency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#D(2)">(2)</span> Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#D(3)">(3)</span> Office; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#D(4)">(4)</span> Organization.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#E">E.</span> Invitees. The Secretary may invite representatives from other agencies and organizations, and individuals involved in the prevention or reduction of morbidity or mortality associated with pregnancy, childbirth, infancy, or early childhood, to attend a Committee meeting if the representative has information that may be necessary to inform the Committee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#F">F.</span> Term of Appointment. Appointed members shall serve for a term of 3 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#G">G.</span> Staffing. The Committee may employ staff in accordance with the State budget.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#H">H.</span> Expenses. Members of the Committee shall serve without compensation, but may be reimbursed for reasonable expenses incurred in the performance of their duties:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#H(1)">(1)</span> In accordance with the standard State travel regulations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#H(2)">(2)</span> As provided in the State budget.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.05#I">I.</span> Chairperson. The Secretary or the Secretary's designee shall serve as Chairperson of the Committee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.06" data-order="|10|11|06|.06|" data-ref-path="10|11|06|.06" class="h__section">.06 Committee Duties.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A">A.</span> To achieve its purpose, the Committee shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(1)">(1)</span> Provide consultation to FIMR teams and other MMQR teams;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(2)">(2)</span> Conduct confidential and anonymous case reviews of morbidity and mortality associated with pregnancy, childbirth, infancy, and early childhood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(3)">(3)</span> Undertake annual statistical analysis of the incidence and cause of morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(4)">(4)</span> Monitor hospital compliance with the Maryland Perinatal System Standards by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(4)(a)">(a)</span> Reviewing documents requested of the hospital in writing or by conducting on-site reviews, or by both; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(4)(b)">(b)</span> Making recommendations to improve or facilitate compliance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#A(5)">(5)</span> Determine factors contributing to morbidity and mortality, and make recommendations for strategies to prevent and reduce morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood throughout the State, including recommendations for changes to law, policy, or practice to prevent and reduce morbidity and mortality and improve the system of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B">B.</span> The Committee may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(1)">(1)</span> Evaluate the continued effectiveness and efficiency of the Statewide morbidity, mortality, and quality review process associated with pregnancy, childbirth, infancy, and early childhood and make or recommend appropriate changes as necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(2)">(2)</span> Establish special panels or ad hoc subcommittees of the Committee as necessary to carry out the duties of the Committee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(3)">(3)</span> Analyze data and review reports or other information from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(3)(a)">(a)</span> FIMR teams;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(3)(b)">(b)</span> Other MMQR teams; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(3)(c)">(c)</span> Other entities which are established for the purpose of addressing an aspect of morbidity, mortality, or quality reviews associated with pregnancy, childbirth, infancy, or early childhood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(4)">(4)</span> Develop protocols for data collection regarding morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(5)">(5)</span> Examine the policies and procedures of State and local agencies, hospitals, and other entities that participate in the system of care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(6)">(6)</span> Review specific cases regarding pregnancy, childbirth, infancy, or early childhood that the Committee considers necessary to perform its duties; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.06#B(7)">(7)</span> Coordinate its activities with other State agencies in order to avoid unnecessary duplication of effort.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.07" data-order="|10|11|06|.07|" data-ref-path="10|11|06|.07" class="h__section">.07 Local Teams — Establishment and Purpose.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#A">A.</span> A jurisdiction shall have a multidisciplinary and multiagency FIMR team or other MMQR team.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B">B.</span> The purpose of a FIMR team is to facilitate the reduction of fetal and infant deaths by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(1)">(1)</span> Conducting confidential case reviews of fetal and infant deaths including the examination of available medical and healthcare information involving fetal and infant mortality; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)">(2)</span> Based on the findings of the case reviews conducted under <a class="internal-link " href="/us/md/exec/comar/10.11.06.07#B(1)" title="">§B(1) of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(a)">(a)</span> Determining factors contributing to fetal and infant deaths;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(b)">(b)</span> Developing recommendations to reduce factors contributing to fetal and infant deaths;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(c)">(c)</span> Recommending strategies to improve the system of care in an effort to prevent or reduce fetal and infant deaths; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(d)">(d)</span> Informing the Committee of changes that affect fetal and infant deaths in:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(d)(i)">(i)</span> Local law;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(d)(ii)">(ii)</span> Policy; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#B(2)(d)(iii)">(iii)</span> Practices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#C">C.</span> A FIMR team shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#C(1)">(1)</span> Analyze fetal and infant deaths to determine contributing system factors; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#C(2)">(2)</span> Make recommendations for systems change as appropriate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D">D.</span> A FIMR team may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D(1)">(1)</span> Evaluate the continued effectiveness and efficiency of the local fetal and infant mortality review process and make appropriate changes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D(2)">(2)</span> Establish protocols in compliance with State statutes and regulations, as applicable, for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D(2)(a)">(a)</span> Data collection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D(2)(b)">(b)</span> Analysis; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.07#D(2)(c)">(c)</span> Reporting.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.08" data-order="|10|11|06|.08|" data-ref-path="10|11|06|.08" class="h__section">.08 FIMR Teams — Membership.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#A">A.</span> Members of a FIMR team shall be appointed by the local health officer of the jurisdiction or be jointly appointed by the health officers of the jurisdictions comprising the multi-jurisdiction local team.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#B">B.</span> A FIMR team shall appoint a chairman from among its membership.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#C">C.</span> A FIMR team shall be multidisciplinary and include professionals and representatives of agencies that provide services or community resources for families in the community and community representatives.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D">D.</span> A FIMR team shall include at least one representative from:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(1)">(1)</span> Public health programs, such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(1)(a)">(a)</span> Maternal and child health;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(1)(b)">(b)</span> Substance abuse; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(1)(c)">(c)</span> Mental health;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)">(2)</span> Health care provider specialties, such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)(a)">(a)</span> Obstetrics;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)(b)">(b)</span> Pediatrics;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)(c)">(c)</span> Social work;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)(d)">(d)</span> Nursing; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(2)(e)">(e)</span> Nurse midwifery; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#D(3)">(3)</span> Hospitals, such as hospital administrators, or professionals with expertise in perinatal services or quality improvement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.08#E">E.</span> A FIMR team may include representatives from other agencies or community organizations involved with the prevention or reduction of fetal and infant deaths.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.09" data-order="|10|11|06|.09|" data-ref-path="10|11|06|.09" class="h__section">.09 MMQR Teams — General.</h3>
                <p>MMQR teams may:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.09#A">A.</span> Inform the Committee of changes that affect morbidity or mortality associated with pregnancy, childbirth, infancy, or early childhood in:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.09#A(1)">(1)</span> Local law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.09#A(2)">(2)</span> Policy; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.09#A(3)">(3)</span> Practice; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.09#B">B.</span> Provide the Committee with requested reports and other information so that the Committee may perform its duties.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.10" data-order="|10|11|06|.10|" data-ref-path="10|11|06|.10" class="h__section">.10 Types of Committee Reviews.</h3>
                <p>The Committee may conduct morbidity, mortality, and quality reviews associated with pregnancy, childbirth, infancy, and early childhood, including but not limited to reviews of the following:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.10#A">A.</span> Individual cases or clusters of cases of morbidity or mortality;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.10#B">B.</span> Maternal or neonatal transport to or from perinatal centers; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.10#C">C.</span> Aggregate or hospital-specific cases of mortality or morbidity associated with pregnancy, childbirth, infancy, or early childhood.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.11" data-order="|10|11|06|.11|" data-ref-path="10|11|06|.11" class="h__section">.11 Access to Records and Information.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A">A.</span> A health care provider, hospital, HIPAA (Health Insurance Portability and Accountability Act of 1996) business associate, or other related entity shall, on written request of the Committee, FIMR team, other MMQR team, or their staff, provide access to records concerning:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(1)">(1)</span> Prepregnancy, prenatal, and postpartum care of the mother;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(2)">(2)</span> Somatic, dental, and behavioral health of the mother;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(3)">(3)</span> The health care provided by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(3)(a)">(a)</span> A health care provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(3)(b)">(b)</span> A health care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(3)(c)">(c)</span> Emergency medical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(4)">(4)</span> Emergency medical services system data on maternal and neonatal transport;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(5)">(5)</span> State vital records data related to morbidity or mortality associated with pregnancy, childbirth, infancy, or early childhood; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(6)">(6)</span> Documentation relevant to the purpose and duties of the Committee, FIMR team, or other MMQR team that is maintained by a State or local government agency, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(6)(a)">(a)</span> Medical examiner investigative information; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#A(6)(b)">(b)</span> Law enforcement investigative information, including police reports.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#B">B.</span> The Committee, FIMR team, or other MMQR team shall assign staff to abstract information from patient medical records and other sources of information to which the Committee, FIMR teams, or other MMQR teams are entitled under <a class="internal-link " href="/us/md/exec/comar/10.11.06.11#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.11#C">C.</span> Information abstracted under <a class="internal-link " href="/us/md/exec/comar/10.11.06.11#B" title="">§B of this regulation</a> shall be de-identified by the abstractor to remove information that would permit the identification of an individual health care recipient before the information may be used to carry out the purpose and duties of the Committee, FIMR team, or other MMQR team.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.12" data-order="|10|11|06|.12|" data-ref-path="10|11|06|.12" class="h__section">.12 Meetings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#A">A.</span> The Committee shall meet at least semiannually.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#B">B.</span> FIMR teams shall meet at least quarterly.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#C">C.</span> A meeting of the Committee, FIMR teams, or other MMQR teams shall be closed to the public and is not subject to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/ggp/ggp.pdf" title="">General Provisions Article, Title 3, Subtitle 3, Annotated Code of Maryland</a>, when the Committee, local FIMR team, or other MMQR team is reviewing cases of pregnancy, childbirth, infancy, or early childhood.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#D">D.</span> The Committee, FIMR team, or other MMQR team may invite an individual who is not a member to attend a Committee, FIMR team, or other MMQR team meeting if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#D(1)">(1)</span> The attendance is approved in advance by the Committee, FIMR team, or other MMQR team chairperson;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#D(2)">(2)</span> Participation of the invited individual is intended to assist the Committee, FIMR team, or other MMQR team in carrying out its duties; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.12#D(3)">(3)</span> Invitees in attendance abide by the same confidentiality and nondisclosure requirements which govern the Committee, FIMR team, and other MMQR team members.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.06.13" data-order="|10|11|06|.13|" data-ref-path="10|11|06|.13" class="h__section">.13 Confidentiality of Records and Information.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#A">A.</span> The following shall be held confidential and may not be released to a person except as provided in this chapter:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#A(1)">(1)</span> Records and information received by the Committee, FIMR team, or other MMQR team;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#A(2)">(2)</span> Documents produced in the case review process; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#A(3)">(3)</span> Minutes of meetings of the Committee, FIMR team, or other MMQR team.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#B">B.</span> Information and records obtained by the Committee, a FIMR team, or other MMQR team are exempt from disclosure under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/ggp/ggp.pdf" title="">General Provisions Article, Title 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#C">C.</span> The Committee, a FIMR team, or other MMQR team may not discuss, disclose, or use information for purposes other than as necessary to carry out the Committee’s, FIMR team’s, or other MMQR team’s duties and purposes under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#D">D.</span> Information that is disclosed to the public by the Committee, FIMR team, or other MMQR team shall be de-identified and may not contain information that would permit the identification of an individual, a health care provider, or a health care facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#E">E.</span> The Committee, a FIMR team, or other MMQR team may release specific findings that relate to aggregate data as well as recommendations made by the Committee, FIMR team, or other MMQR team to prevent and reduce morbidity and mortality, and this information shall be public record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#F">F.</span> The Committee, FIMR team, other MMQR team, or their staff shall maintain the confidentiality of information used or addressed at meetings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#G">G.</span> A person in attendance at a meeting of the Committee, a FIMR team, or other MMQR team may not testify or be required to testify as to what transpired at that part of the meeting that is closed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/ggp/ggp.pdf" title="">General Provisions Article, Title 3, Subtitle 3, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#H">H.</span> A member of the Committee, FIMR team, other MMQR team, their staff, or invitees may not be questioned in a civil or criminal proceeding regarding information presented at or opinions formed as a result of a closed Committee, FIMR team, or other MMQR team meeting.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#I">I.</span> A member of the Committee, FIMR team, other MMQR team, their staff, or invitees, may testify in a civil or criminal proceeding to information that is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#I(1)">(1)</span> Obtained independent of the Committee, FIMR team, or other MMQR team; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#I(2)">(2)</span> Publicly available, except as otherwise provided by law.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#J">J.</span> Information, documents, and records of the Committee, a FIMR team, or other MMQR team are not subject, in a civil or criminal proceeding, to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#J(1)">(1)</span> Subpoena;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#J(2)">(2)</span> Discovery; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#J(3)">(3)</span> Introduction as evidence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#K">K.</span> Information, documents, and records obtained by the Committee, a FIMR team, or other MMQR team that are available from other sources may be subject, as provided by applicable law, to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#K(1)">(1)</span> Subpoena;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#K(2)">(2)</span> Discovery; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#K(3)">(3)</span> Introduction into evidence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.06.13#L">L.</span> A person may not be held liable for civil damages or subject to a criminal or disciplinary action for good faith efforts made to comply with the provisions of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.07" data-order="|10|11|07|" data-ref-path="10|11|07" class="h__chapter">Chapter 07 Prohibition of Sale of Baby Bumper Pads</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 26, 2012 (39:23 Md R. 1532)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §22-501 et seq., Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.07.01" data-order="|10|11|07|.01|" data-ref-path="10|11|07|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#B(1)">(1)</span> “ASTM Standards” means the standard consumer safety performance specifications for infant bedding and related accessories set by the American Society for Testing and Materials (ASTM).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#B(2)">(2)</span> “Baby bumper pads” means a pad or pads of non-mesh material resting directly above the mattress in a crib, running the circumference of the crib or along the length of any of the interior sides of the crib, and intended to be used until the age that an infant pulls to stand.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#B(3)">(3)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.01#B(4)">(4)</span> “Hazardous material” has the meaning stated in Health-General Article, §22-501, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.07.02" data-order="|10|11|07|.02|" data-ref-path="10|11|07|.02" class="h__section">.02 General Provisions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.02#A">A.</span> Baby bumper pads are hereby declared to be a hazardous material and may not be shipped or sold to a purchaser in Maryland beginning June 21, 2013.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.02#B">B.</span> ASTM Standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.02#B(1)">(1)</span> After notification that ASTM has adopted a new voluntary standard for baby bumper pads, the Secretary may provide an opportunity for public comment on whether the new ASTM Standards should replace the prohibition contained in <a class="internal-link " href="/us/md/exec/comar/10.11.07.02#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.07.02#B(2)">(2)</span> Within 60 days after the close of public comment, the Secretary may issue an order permitting the sale of baby bumper pads that comply with the new ASTM Standards if the Secretary determines that such bumper pads are not a danger to the public health and safety.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.02#C">C.</span> The Secretary may issue an order suspending this chapter for covered baby bumper pads if the Consumer Product Safety Commission affirmatively finds that the benefits of certain baby bumper pads exceed the risks.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.07.03" data-order="|10|11|07|.03|" data-ref-path="10|11|07|.03" class="h__section">.03 Violations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.03#A">A.</span> A notice of violation will be issued by the Department to any person found to have shipped or sold a baby bumper pad to a purchaser in Maryland after June 21, 2013.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.07.03#B">B.</span> A person who, after being issued a notice of violation, ships or sells a baby bumper pad to a purchaser in Maryland shall be subject to a civil fine of not more than $500 for each baby bumper pad shipped or sold in violation of this subtitle.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.11.08" data-order="|10|11|08|" data-ref-path="10|11|08" class="h__chapter">Chapter 08 Abortion Care Disclosure</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 16, 2024 (51:18 Md. R. 809)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §4-302.5 Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.11.08.01" data-order="|10|11|08|.01|" data-ref-path="10|11|08|.01" class="h__section">.01 Purpose.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#B(1)">(1)</span> “ASTM Standards” means the standard consumer safety performance specifications for infant bedding and related accessories set by the American Society for Testing and Materials (ASTM).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#B(2)">(2)</span> “Baby bumper pads” means a pad or pads of non-mesh material resting directly above the mattress in a crib, running the circumference of the crib or along the length of any of the interior sides of the crib, and intended to be used until the age that an infant pulls to stand.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#B(3)">(3)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.01#B(4)">(4)</span> “Hazardous material” has the meaning stated in Health-General Article, §22-501, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.08.02" data-order="|10|11|08|.02|" data-ref-path="10|11|08|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#A">A.</span> In this chapter, the following terms have the meaning indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B(1)">(1)</span> “Electronic health network” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.09.02" title=".02 Definitions.">COMAR 10.25.09.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B(2)">(2)</span> “Health information exchange” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.18.02" title=".02 Definitions.">COMAR 10.25.18.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B(3)">(3)</span> “Mifepristone data” means all medication or related codes pertaining to mifepristone use during any stage of pregnancy, and excludes any codes pertaining to the use of mifepristone for Cushing’s syndrome.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B(4)">(4)</span> “Protected Health Care Commission” means the group established under Health-General Article, §4-310, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.11.08.02#B(5)">(5)</span> “Secretary” means the Secretary of the Maryland Department of Health.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.08.03" data-order="|10|11|08|.03|" data-ref-path="10|11|08|.03" class="h__section">.03 Abortion Care Codes.</h3>
                <p>A health information exchange and an electronic health network shall restrict the disclosure of the abortion care medical diagnosis codes and current procedural terminology (CPT) codes listed in the tables below.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.03#A">A.</span> List of Medical Diagnosis Codes.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) Code</th>
                        <th>Description</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td>O04—O04.89</td>
                        <td>Complications following (induced) termination of pregnancy</td>
                      </tr>
                      <tr>
                        <td>O07—O07.4</td>
                        <td>Failed attempted termination of pregnancy</td>
                      </tr>
                      <tr>
                        <td>O31.3—O31.33X9</td>
                        <td>Continuing pregnancy after selective reduction of one fetus or more</td>
                      </tr>
                      <tr>
                        <td>Z33.2</td>
                        <td>Encounter for elective termination of pregnancy</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.03#B">B.</span> List of the Current Procedural Terminology (CPT®) Codes.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>CPT® Code</th>
                        <th>Description</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td>59840</td>
                        <td>Induced abortion, by dilation and curettage</td>
                      </tr>
                      <tr>
                        <td>59841</td>
                        <td>Induced abortion, by dilation and evacuation</td>
                      </tr>
                      <tr>
                        <td>59850</td>
                        <td>Induced abortion, by 1 or more intra-amniotic injections, including hospital admission and visits, delivery of fetus and secundines</td>
                      </tr>
                      <tr>
                        <td>59851</td>
                        <td>Induced abortion, by 1 or more intra-amniotic injections, including hospital admission and visits, delivery of fetus and secundines; with dilation and curettage and/or evacuation</td>
                      </tr>
                      <tr>
                        <td>59852</td>
                        <td>Induced abortion, by 1 or more intra-amniotic injections, including hospital admission and visits, delivery of fetus and secundines; with hysterotomy (failed intra-amniotic injection)</td>
                      </tr>
                      <tr>
                        <td>59855</td>
                        <td>Induced abortion, by 1 or more vaginal suppositories (e.g. prostaglandin) with or without cervical dilation (e.g., laminaria), including hospital admission and visits, delivery of fetus and secundines</td>
                      </tr>
                      <tr>
                        <td>59856</td>
                        <td>Induced abortion, by 1 or more vaginal suppositories (e.g. prostaglandin) with or without cervical dilation (e.g., laminaria), including hospital admission and visits, delivery of fetus and secundines; with dilation and curettage and/or evacuation</td>
                      </tr>
                      <tr>
                        <td>59857</td>
                        <td>Induced abortion, by 1 or more vaginal suppositories (e.g. prostaglandin) with or without cervical dilation (e.g., laminaria), including hospital admission and visits, delivery of fetus and secundines; with hysterotomy (failed medical evacuation)</td>
                      </tr>
                      <tr>
                        <td>59866</td>
                        <td>Multifetal pregnancy reduction(s)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.08.04" data-order="|10|11|08|.04|" data-ref-path="10|11|08|.04" class="h__section">.04 Mifepristone Data Codes.</h3>
                <p>A health information exchange and an electronic health network shall restrict the disclosure of mifepristone data Healthcare Common Procedure Coding System (HCPCS) codes and medication codes listed in the tables below.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.04#A">A.</span> List of Healthcare Common Procedure Coding System ( HCPCS) Level 2 Codes.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>HCPCS Level 2 Code</th>
                        <th>Description</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td>S0190</td>
                        <td>Mifepristone, oral, 200mg</td>
                      </tr>
                      <tr>
                        <td>S0199</td>
                        <td>Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by human chorionic gonadotropin (HCG), ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drug/medications</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.11.08.04#B">B.</span> List of Medication Codes.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>National Drug Code</th>
                        <th>Trade Name</th>
                        <th>Labeler/Manufacturer</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="bottom">64875-0001-01</td>
                        <td data-vertical-align="bottom">Mifeprex (oral mifepristone)</td>
                        <td data-vertical-align="bottom">Danco</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="bottom">43393-001</td>
                        <td data-vertical-align="bottom">Generic mifepristone tablets</td>
                        <td data-vertical-align="bottom">GenBIOPro</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="bottom">43393-001-06</td>
                        <td data-vertical-align="bottom">Generic mifepristone tablets</td>
                        <td data-vertical-align="bottom">GenBIOPro</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="bottom">43393000106</td>
                        <td data-vertical-align="bottom">Generic mifepristone tablets</td>
                        <td data-vertical-align="bottom">GenBIOPro</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.08.05" data-order="|10|11|08|.05|" data-ref-path="10|11|08|.05" class="h__section">.05 Restrictions on Disclosure of Mifepristone Data.</h3>
                <p>Data is restricted in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.18" title="Chapter 18 Health Information Exchanges: Privacy and Security of Protected Health Information">COMAR 10.25.18</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.07" title="Chapter 07 Certification of Electronic Health Networks and Medical Care Electronic Claims Clearinghouses">COMAR 10.25.07</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.11.08.06" data-order="|10|11|08|.06|" data-ref-path="10|11|08|.06" class="h__section">.06 Sensitive Health Services.</h3>
                <p>The Secretary shall determine what sensitive health services are subject to restriction under this chapter based on the recommendations of the Protected Health Care Commission.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.10" aria-label="Subtitle 10 LABORATORIES">
                <div class="h__ui">Previous</div>
                <span>Subtitle 10 LABORATORIES</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.12" aria-label="Subtitle 12 ADULT HEALTH">
                <div class="h__ui">Next</div>
                <span>Subtitle 12 ADULT HEALTH</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
